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THE MEDICAL NECESSITY DEFENSE AND DE
MINIMIS PROTECTION FOR PATIENTS WHO
WOULD BENEFIT FROM USING MARIJUANA
FOR MEDICAL PURPOSES: A PROPOSAL TO
ESTABLISH COMPREHENSIVE PROTECTION
UNDER FEDERAL DRUG LAWS
[M]arijuana, in its natural form, is one of the safest
therapeutically active substances known to man.... One
must reasonably conclude that there is accepted safety for use
of marijuana under medical supervision. To conclude
otherwise, on the record, would be unreasonable, arbitrary,
and capricious.'
I. INTRODUCTION
The marijuana plant has been known to exist for centuries.2 Yet, its
usage remains a controversial subject even today.3 There are many
American citizens who have been stricken with debilitating and terminal
diseases, such as cancer, multiple sclerosis ("MS"), and Acquired
Immune Deficiency Syndrome ("AIDS"). 4 Many of those afflicted have
voiced their desires to have marijuana made available to them for its
palliative uses.5  However, because of prejudice, bias, and faulty
1 LESTER GRINSPOON, M.D. & JAMES B. BAKALAR, MARIHUANA, THE FORBIDDEN MEDICINE
15 (1993) (quoting Administrative Law Judge Francis J. Young).
2 See infra note 31 and accompanying text.
3 See infra notes 93-100 and accompanying text.
4 U.S. CENSUS BUREAU, STATISTICAL ABSTRACT OF THE UNITED STATES 96 (120th ed. 2000).
For example, the death rate for males with cancer was an average of 214.6 deaths out of
100,000 in 1997 and 213.6 deaths per each group of 100,000 in 1998. Id. For females with
cancer, the death rate averaged 189.2 deaths out of 100,000 in 1997 and 187.7 deaths per
each group of 100,000 in 1998. Id. Moreover, it is estimated that there are 920,000 people
afflicted with HIV and AIDS in North America. Headline Watch, at
http://www.mayoclinic.com/findinformation/conditioncenters/invoke.cfm (last visited
Jan. 31, 2002). Approximately 45,000 people have become infected in the year 2000 alone.
Id. Of those afflicted with HIV/AIDS, eighty percent are male. Id. By comparison, it is
estimated that there are 36.1 million people living with AIDS worldwide. Id.
5 MARIJUANA, MEDICINE & THE LAW 231 (R.C. Randall ed., 1988). For example, one
patient noted,
The effects were so dramatic that it was immediately obvious to me
that marijuana was somehow having a beneficial effect on the
symptoms of my MS. After that experience I smoked marijuana
whenever I felt nauseated or started to vomit. When I smoked
marijuana it controlled my vomiting, stopped the nausea, and
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reasoning, the federal government has determined that it will not allow
its citizens to realize the benefits of medicinal marijuana. 6
This Note will analyze the problems that are associated with the
current environment of disunion between the relevant state and federal
laws regarding medicinal marijuana.7 While the medical necessity
defense may still be available as a defense for possession of medicinal
marijuana under the Federal Controlled Substances Act, it will provide
de minimis protection at best.8 In order for those afflicted with diseases
such as cancer and AIDS to receive protection from the current
applicable laws, they must rely on whether a court would consider their
condition serious enough to warrant a defense of medical necessity. 9
Moreover, the medical necessity defense is not sufficient to provide
prescribing physicians, manufacturers, or distributors any real
protection.10 Therefore, the federal laws concerning marijuana must be
changed. 1 The change must come at the federal level in order to provide
clarity and uniformity. 12 In doing so, patients' access to medicinal
marijuana would not have to be determined by the state in which they
reside.13
This Note begins by providing a comprehensive look at the history
of medicinal marijuana in the United States from the mid-nineteenth
century to the present.14 In doing so, Part II will establish the shift from
marijuana being perceived as a local problem to one sufficient to
necessitate the intervention of the laws of the federal government.1  A
number of factors contributed to this shift, and each will be considered.16
These factors include prejudice toward the Mexican immigrants who
provided a labor supply in the early 1900s, the prohibition of alcohol,
increased my appetite. I began smoking marijuana in order to eat and
to regain my weight.
Id. See also infra note 29 and accompanying text.
6 See infra notes 41-56, 79-87 and accompanying text.
7 See infra notes 83, 89-90 and accompanying text.
I See infra note 189 and accompanying text.
9 PAUL H. ROBINSON, CRIMINAL LAW § 1.2, at 13 (1997) (noting that "the criminal law
[must] have moral credibility with those sought to be deterred"); see also infra note 118 and
accompanying text.
10 See infra notes 123-24 and accompanying text.
11 See infra Part IV for section 3 of the model statute: Effect on Current Marijuana Laws.
12 See infra Part IV for section 3 of the model statute: Effect on Current Marijuana Laws.
13 See infra Part IV for section 3 of the model statute: Effect on Current Marijuana Laws.
14 See infra notes 28-40 and accompanying text.
15 See discussion infra Part II.B.
16 See infra notes 41, 47, 51 and accompanying text.
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and the role of an early Commissioner of the Federal Bureau of
Narcotics. 17
Next, this Note will elucidate the response that the federal
government provided to the states' cries for assistance in battling not
only marijuana itself but also its users.18 In doing so, the various statutes
that the government has passed will be described and analyzed.' 9
Additionally, the interpretations of these statutes by the various courts
will be provided.20
Part II will then outline the many attempts that have been made to
change the current system of marijuana prohibition.21 Among these
attempts are various state-based initiatives and the activities of lobbying
groups which have tried to use the courts to alter current marijuana
laws.22 Next, this Note will analyze defenses that have been asserted by
defendants, including the use of the First Amendment and the defense of
medical necessity.23
This Note will then provide an analysis of recent United States
Supreme Court jurisprudence regarding medicinal marijuana and the
role of federalism. 24 The analysis of this jurisprudence will be followed
by this Note's contribution to the current discourse in this area of law.25
Because of the number of interests at stake, any change that is to be
effectuated must necessarily be accomplished by a complete and multi-
faceted approach.26 Because marijuana laws do not exist in a vacuum,
each of these interests must be considered and incorporated into any
newly proposed approach to the regulation of medicinal marijuana.27
17 See infra notes 41-56 and accompanying text.
18 See discussion infra Part II.B.
19 See infra notes 79, 83-86 and accompanying text.
20 See infra notes 77, 79, 86 and accompanying text.
21 See discussion infra Part II.C.
22 See infra notes 88-90, 101-108 and accompanying text; infra Part II.C.2.
23 See infra notes 109-120 and accompanying text.
24 See discussion infra Part 1I.D; see also infra Part III (discussing the Commerce Clause
jurisprudence of the Supreme Court and its implications for medical marijuana).
25 See discussion infra Part IV.
26 See infra Part IV for section I of the model statute: Goals and Purposes.
27 See infra Part IV for section 2 of the model statute: Definitions.
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II. THE HISTORICAL BACKGROUND AND DEVELOPMENT OF LAWS
REGULATING MEDICAL MARIJUANA
A. Medicinal Use of Marijuana
The uses of the marijuana plant are multifarious. 28 The most
significant, and often overlooked, of these purposes is marijuana's
therapeutic uses.29 The healing properties of marijuana have been
28 This Note shall use the term "marijuana" as it is used in the common parlance to refer
to the cannabis plant. See 21 U.S.C. § 802(16) (2000). This subsection defines marijuana as:
The term "marihuana" means all parts of the plant Cannabis sativa L.,
whether growing or not; the seeds, thereof; the resin extracted from
any part of such plant; and every compound, manufacture, salt,
derivative, mixture, or preparation of such plant, its seeds or resin.
Such term does not include the mature stalks of such plant, fiber
produced from such stalks, oil or cake made from the seeds of such
plant, any other compound, manufacture, salt, derivative, mixture, or
preparation of such mature stalks (except the resin extracted
therefrom), fiber, oil, or cake, or the sterilized seed of such plant which
is incapable of germination.
Id.
29 LYNN ZIMMER & JOHN P. MORGAN, MARIJUANA MYTHS, MARIJUANA FACTS: A REVIEW
OF THE SCIENTIFIC EVIDENCE 16 (1997). "Marijuana has been shown to be effective in
reducing nausea induced by cancer chemotherapy, stimulating appetite in AIDS patients,
and reducing intraocular pressure in people with glaucoma. There is also appreciable
evidence that marijuana reduces muscle spasticity in patients with neurological disorders."
Id. Marijuana has also been shown to be useful in promoting weight gain, reducing muscle
spasticity in patients with spinal cord injuries and multiple sclerosis, and lessening tremors
associated with those afflicted with multiple sclerosis. Id. at 17. Additionally, research has
indicated that marijuana may have other therapeutic applications, such as use as an
analgesic, antiepileptic, antidepressant, antibiotic, psychotherapeutic aid, and as a means of
facilitating withdrawal from addictions associated with opiates and alcohol. LESTER
GRINSPOON, M.D., MARIHUANA RECONSIDERED 226 (1971). Furthermore, anecdotal
evidence from patients indicates that marijuana may also be useful in alleviating migraine
headaches, depression, insomnia, and chronic pain. ZIMMER & MORGAN, supra, at 17. For
those patients with AIDS whose appetites become suppressed due to the illness and the
correlative prescription medicines, marijuana causes a drop in the level of blood sugar,
and, therefore, stimulates and increases a hunger response in the patients. Matthew W.
Grey, Comment, Medical Use of Marijuana: Legal and Ethical Conflicts in the Patient/Physician
Relationship, 30 U. RICH. L. REV. 249, 252 (1996); see also JOEL SIMON HOCHMAN, M.D.,
MARIJUANA AND SOCIAL EVOLUTION 55 (1972). Additionally, marijuana possesses what is
referred to as the "reverse tolerance phenomenon." HOCHMAN, supra, at 54. The "reverse
tolerance phenomenon" means that a patient who regularly ingests marijuana will require
less of the drug to attain the desired effect in regard to the particular user. Id. Thus,
marijuana stands in contradistinction to other psychoactive drugs, including alcohol,
barbiturates, amphetamines, and opiates in that the other psychoactive drugs require the
user to increase their dosages in order to achieve the desired effects. Id.
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known and utilized for centuries.30 One of the earliest recommendations
for marijuana as a plant with healing properties was over five thousand
years ago.31 Nonetheless, the active cultivation of the plant in the early
history of the United States was more likely for the hempen fibers
contained in the stalks of the plant rather than for its therapeutic
qualities. 32 The recreational use of marijuana on a national scale has
been linked to the 1876 World Exposition in Philadelphia.33 Among the
other exposition booths was a tent where the Sultan from the country of
Turkey introduced the use of hookahs, or water pipes, for smoking
marijuana and its derivative hashish.34
30 See RICHARD EVANS SCHULTES & ALBERT HOFFMAN, PLANTS OF THE GODS: THEIR
SACRED, HEALING AND HALLUCINOGENIC POWERS 72, 93 (1992). Research has identified at
least three species of cannabis: Cannabis indica, Cannabis ruderalia, and Cannabis sativa. Id. at
92. While all three species contain the cannabinolic compounds (most significantly delta-9-
THC, or Tetrahydrocannabinol) that make up the psychoactive property of marijuana, they
can be distinguished by such characteristics as growth habits and geographic distribution.
Id. Researcher Joel Simon Hochman has noted that the THC found in marijuana produces a
"painless stupor" effect in the user which is similar to that of morphine, which is used to
alleviate pain in those who sustain serious injuries. HOCHMAN, supra note 29, at 55.
However, unlike morphine, marijuana does not produce the same withdrawal effects on
the user. Id. Moreover, the potential for abuse of marijuana by the patient is comparatively
low, even for chronic users. Id. at 59.
31 HOCHMAN, supra note 29, at 96. Shen-Nung was a Chinese emperor-herbalist who
espoused marijuana's use for such maladies as malaria and rheumatic pains. Id. Contra
DRUGS AND DRUG POLICY IN AMERICA 123 (Steven R. Belenko ed., 2000) (discussing that
Shen-Nung may have been a mythical figure and that the treatise attributed to him was
compiled later). Further instances of marijuana's medicinal use abound in the history of
folk-medicines in India, Africa, Mexico, South America, and Medieval Europe. SCHULTES &
HOFFMAN, supra note 30, at 72, 99. For example, during his travels in 1271, Marco Polo
recorded observations of marijuana's usage. Id. at 99.
32 GRINSPOON, supra note 29, at 11. The fibers are known to be quite strong and can be
used for making such goods as rope and clothing. Id. In fact, the word "canvas" is derived
from the Latin term cannabis. WEBSTER'S NINTH NEW COLLEGIATE DICTIONARY 203 (1986).
Interestingly, George Washington is known to have cultivated hemp at his Mount Vernon
home for making rope. GLEN HANSON ET AL., DRUGS AND SOCIETY 367 (6th ed. Jones &
Bartlett 2000). Furthermore, there is some indication that he used marijuana medicinally.
Id. Washington once noted in his writings that he had forgotten to separate the male and
female plants, which is a process used because an unpollinated female plant provides more
resin. Id. Hemp was also grown in the Jamestown colony and by the Pilgrims at
Plymouth. Id.
33 Hooked: Illegal Drugs and How They Got That Way (History Channel 2000) [hereinafter
Hooked].
34 Id. Following the World Exposition, a number of "smoking parlors" began to appear
in major cities across the United States. Id. However, they did not become popular until
alcohol became illegal with the passage of the Eighteenth Amendment. Id.
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However, by 1850, marijuana had officially been recognized for its
therapeutic uses by its inclusion in the highly selective United States
Pharmacopoeia drug reference manual. 35 Prior to 1937, marijuana was not
federally regulated. 36 Thus, the states were left to regulate marijuana as
they deemed necessary. 37 It was not until 1914 that state laws began to
restrict the sale and possession of marijuana.38  Border states, in
particular, became concerned with the perceived adverse effects of
marijuana on its citizenry. 39 This concern would eventually make its
way across the United States.4°
35 DRUGS AND DRUG POLICY IN AMERICA, supra note 31, at 123, 127. Marijuana was
identified as Extractum Cannabis (Extract of Hemp) and remained listed until the early
1940s. Id. at 127. Tincture of cannabis was manufactured in the late 1800s by
pharmaceutical companies such as Parke-Davis, Lilly, and Squibb. LARRY "RAT-O"
SLOMAN, REEFER MADNESS: THE HISTORY OF MARIJUANA IN AMERICA 22 (The Bobbs-Merrill
Co. 1998) (1979). Marijuana was also included in treatises such as The National Formulary
and the United States Dispensatory. Id. Marijuana was subsequently removed from the
United States Pharmacopoeia in 1941 following passage of the Marijuana Tax Act of 1937.
DRUG LEGALIZATION 143 (Scott Barbour ed., 2000); see also infra note 57 and accompanying
text.
36 GRINSPOON, supra note 29, at 10; see also Allison L. Bergstrom, Medical Use of
Marijuana: A Look at Federal and State Responses to California's Compassionate Use Act, 2
DEPAUL J. HEALTH CARE L. 155, 158 (1997); Lauretta Higgins Wolfson, A Quality of Mercy:
The Struggle of the AIDS-Afflicted to Use Marijuana As Medicine, 22 T. JEFFERSON L. REV. 1, 4
(1999) (noting also that until 1937, there were twenty-eight medications containing
marijuana that were available to physicians to prescribe to their patients).
37 See infra note 57 and accompanying text.
38 DRUGS AND DRUG POLICY IN AMERICA, supra note 31, at 137. In 1914, El Paso, Texas,
enacted a law proscribing the sale and possession of marijuana. Id. The State of Texas
followed suit by enacting its own laws regarding nonmedicinal marijuana in 1919 and 1923.
Id.
39 Id. at 135-40. For example, New Mexico passed a law criminalizing marijuana in 1923,
Louisiana in 1924, and Colorado in 1927. Id. Indeed, by 1927, the number of states which
had enacted anti-marijuana laws was fifteen, and by 1931, the number had increased to
twenty-nine. Id. at 133. Significantly, most of the state laws provided exceptions for
medicinal use of marijuana. Id. at 135-40. It was not the adverse effects on health that these
laws were concerned with, but rather a perceived correlation between the Mexican
immigrants and farm laborers, their marijuana use, and an increased disposition towards
criminality. Id. at 136-37; see also State v. Navaro, 26 P.2d 955, 960 (Utah 1933). In Navaro,
the Utah Supreme Court upheld a conviction for marijuana possession under Utah's 1927
revised statute. Navaro, 26 P.2d at 960. The court also examined similar statutes of
neighboring states in assessing a definition of marijuana. Id. at 956-60; see also infra note 40.
40 RICHARD J. BONNIE & CHARLES H. WHITEBREAD II, A HISTORY OF MARIJUANA
PROHIBITION IN THE UNITED STATES 52 (1975). The following is a list of states, by date, that
passed legislation forbidding marijuana distribution for nonmedical purposes: in 1914:
Maine and Massachusetts; in 1915: California and Vermont; in 1918: Rhode Island; in 1921:
Iowa; in 1923: Arkansas, Montana, Nevada, Oregon, and Washington; in 1927: Idaho,
Kansas, Nebraska, New York, and Ohio; in 1929: Indiana, Michigan, and Wyoming; in
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During the early twentieth century, a number of factors coalesced
which forced the federal government to take notice of a perceived
marijuana problem in the United States. One significant factor was an
implicit, often overt, racial bias towards those immigrants who brought
the use of marijuana as a part of their native culture to the United
States. 41 At one time, immigrant labor was welcomed because of the
relative prosperity in the United States and the need for additional
workers in less desirable occupations.4 2 Additionally, the urbanization
that was taking place across the country had lured people away from
farms and into burgeoning industries in the growing cities, thus creating
a void that needed to be filled by immigrant laborers.43 However, as
this prosperity subsided during the Depression era, this surplus labor
was seen as undesirable because the immigrant laborers were perceived
to be taking jobs away from American citizens.44 Moreover, other
cultural differences, such as religion, custom, and clothing, created
further opportunities for discriminatory treatment against these new
laborers.45  As a result, the states in the southwestern United States
began applying pressure to the federal government to pass laws that
1930: Mississippi; in 1931: Alabama, Arizona, Illinois, and South Dakota; in 1933:
Delaware, North Dakota, Oklahoma, and Pennsylvania. Id.
41 GRINSPOON, supra note 29, at 14-15. Dr. Grinspoon also provides a particularly telling
quote from the New Orleans Medical and Surgical Journal from 1931:
The debasing and baneful influence of hashish and opium is not
restricted to individuals but has manifested itself in nations and races
as well. The dominant race and most enlightened countries are
alcoholic, whilst the races and nations addicted to hemp and opium,
some of which once attained to heights of culture and civilization have
deteriorated both mentally and physically.
Id. at 16; see also DRUGS AND DRUG POLICY IN AMERICA, supra note 31, at 151. This text also
provides a similarly mordant quote from an American Medical Association Committee on
Legislative Activities from 1937: "Your committee also recognizes that in the border states
the extensive use of the marijuana weed by a certain type of people would be hard to control."
DRUGS AND DRUG POLICY IN AMERICA, supra note 31, at 151 (emphasis added); see SLOMAN,
supra note 35, at 30 (describing the concern regarding marijuana use in New Orleans as
early as 1910 by African Americans and jazz musicians and the fear that marijuana use
would be undertaken by white school children).
42 Hooked, supra note 33. The less desirable occupations generally included work that
was agricultural in nature. Id.
43 BONNIE & WHITEBREAD II, supra note 40, at 10 (noting also that the influx of laborers to
the cities of America created poverty and disruption in those growing cities).
4 Hooked, supra note 33; see also BONNIE & WHITEBREAD II, supra note 40, at 45 (noting the
difficulties and prejudices that Mexican laborers faced as they migrated into the larger
cities in the northern United States).
45 BONNIE & WHITEBREAD II, supra note 40, at 10.
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would assist them in their struggle to deport and imprison these
immigrants.46
A second significant factor that forced the federal government to
take notice of marijuana was the prohibition of alcohol.47 During the
time of Prohibition, marijuana remained a legal substance under federal
law.48 As a result, marijuana became increasingly popular because it was
cheaper and easier to obtain than alcohol.49  However, after the
Eighteenth Amendment was repealed, manufacturers of alcohol became
another force behind the anti-marijuana lobby.50
A third factor, and quite possibly the most significant, was the moral
crusade of Harry J. Anslinger, the Commissioner of the Federal Bureau
of Narcotics. 5 1 Prior to his appointment, Anslinger was known for his
work in support of Prohibition.52  As he ascended to various
governmental positions, including work as an inspector for the War
Department and participation in various consulships in Germany,
Venezuela, and the Bahamas, he gained a reputation for being a
preeminent bureaucrat. 53 Faced with an annual budget of $1,411,260 and
just over 300 agents, Anslinger, now acting as Commissioner, was
46 Hooked, supra note 33.
47 U.S. CONST. amend. XVIII (1919), repealed by U.S. CONST. amend. XXI. Congress
enacted the Eighteenth Amendment in 1919 and repealed the Amendment in 1933.
HANSON ET AL., supra note 32, at 203. Thus, the time span involved correlates to the time
frame in which the states were enacting their anti-marijuana laws. See supra note 40.
48 See supra note 47 and accompanying text; see also infra note 57.
49 DRUGS AND DRUG POLICY IN AMERICA, supra note 31, at 133; see also Hooked, supra note
33 (discussing the increase in "smoking parlors" following Prohibition). Smoking parlors
were described as essentially similar to taverns in that they were a place where people
would congregate to smoke marijuana and socialize. Hooked, supra note 33; see also DRUGS
AND DRUG POLICY IN AMERICA, supra note 31, at 59 (discussing a study conducted by the
Treasury Department that associated the prohibition of alcohol to an increase in drug use
and addiction).
50 GRINSPOON, supra note 29, at 16. Dr. Grinspoon discussed how the post-Prohibition
liquor industry was hoping for a "golden age of prosperity" that was threatened by the
availability of marijuana as a cheaper alternative to alcohol. Id.
51 SLOMAN, supra note 35, at 31. In 1930, Anslinger was appointed to his Commissioner's
post in the recently created Federal Bureau of Narcotics. Id. at 36. It was from this post
that Anslinger mounted a fervent attack against the perceived marijuana menace. Id. at 45-
47.
52 Id. at 31. Anslinger honed his crusading tactics by being appointed Assistant
Commissioner of Prohibition. Id.
53 Id. at 32; see also BONNIE & WHITEBREAD II, supra note 40, at 66 (noting how Anslinger
worked with the British in control of the Bahamas to aid Prohibition in the United States by
disrupting the bootlegging of liquor from the West Indies); Hooked, supra note 33.
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presented with the formidable task of controlling a weed that grew wild
across the United States.54  In order to surmount this seemingly
unrealizable objective, it became necessary for Anslinger to institute a
campaign of propaganda so as to convince the American public of the
perceived problems of marijuana use and addiction.55 As the campaign
of Anslinger and the Federal Bureau of Narcotics gained momentum, the
pressure increased for legislative action at the federal level of
government. 56
B. The Federal Government Responds
The federal government acted upon this "new threat" to the
American way of life by enacting the 1937 Marijuana Tax Act.57 Prior to
this enactment, marijuana had remained a legal substance under federal
law.5 8  Interestingly, it was the medical community which most
54 SLOMAN, supra note 35, at 41.
55 Hooked, supra note 33. William Randolph Hearst's newspaper chain assisted
Anslinger's campaign of scare tactics and distorted truths. BONNIE & WHtTEBREAD II, supra
note 40, at 100-01. For example, one of Hearst's editorials is particularly indicative of the
content of this propaganda machine, where Hearst offered that, "[i]n recent years, the
insidious and insanity producing marihuana has become among the worst of the narcotic
banes, invading even the school houses of the country .... " Id. at 100. Anslinger himself
contributed articles with titles such as Marihuana: Assassin of Youth. Id. at 98. Interestingly,
these same tactics are utilized yet today in the United States' continued war on drugs. See
ZIMMER & MORGAN, supra note 29, at 158-60. Much to the consternation of Harry Anslinger
and the Federal Bureau of Narcotics, a report commissioned by the Mayor of New York
City, Fiorello LaGuardia, undermined the thrust of the anti-marijuana movement. DRUGS
AND DRUG POLICY IN AMERICA, supra note 31, at 156-57. The LaGuardia report concluded,
inter alia, that "smoking marihuana does not lead to addiction in the medical sense of the
word ... marihuana is not the determining factor in the commission of major crimes ...
marihuana smoking is not widespread among school children" and that "[tihe publicity
concerning the catastrophic effects of marihuana smoking in New York City is
unfounded." Id. at 157-58. These findings all ran contrary to the message that Anslinger
and the Federal Bureau of Narcotics were trying to convey to the American public. Id.
56 DRUGS AND DRUG POLICY IN AMERICA, supra note 31, at 114.
57 Marijuana Tax Act of 1937, ch. 553, Pub. L. No. 75-238, 50 Stat. 551 (1937). It has been
noted that "the [Marijuana Tax Act] was tied neither to scientific study nor to enforcement
need." BONNIE & WHITEBREAD II, supra note 40, at 174. The constitutionality of the
Marijuana Tax Act was upheld by the United States Supreme Court in United States v.
Sanchez. 340 U.S. 42, 44-45 (1950) (holding that, despite the prohibitive regulatory effect,
the tax was a legitimate exercise of the government's taxing power).
58 DRUGS AND DRUG POLICY IN AMERICA, supra note 31, at 146. The federal government
had enacted other laws regarding narcotic drugs. Id. The most significant of these was the
Harrison Act of 1914. Harrison Anti-Narcotic Act, ch. 1, Pub. L. No. 63-223, 38 Stat. 785
(1914) (codified as part of 21 U.S.C. §§ 801-904 (2000)). The Harrison Act regulated narcotic
drugs, specifically opiates and coca leaves, at the federal level. DRUGS AND DRUG POLICY IN
AMERICA, supra note 31, at 49. It required anyone involved in the manufacture and
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strenuously objected to this new legislation.59 During the congressional
hearings on the proposed Marijuana Tax Act, Dr. William C. Woodward
testified on behalf of the American Medical Association. 60 His testimony
would be the only dissenting view allowed to testify at the hearings. 61
Dr. Woodward challenged the proposal on two grounds.62 First, Dr.
Woodward noted the lack of evidence that had been offered by those
favoring the passage of the Act.63 Secondly, he feared that if the
Marijuana Tax Act was enacted, scientific research into the uses and
effects of marijuana would no longer make any advances. 64 Because of
distribution of narcotics to register with the proper authorities and pay a tax or license fee
for such service. Id. The Harrison Act had a deterrent effect on physicians who would
have otherwise prescribed the medicine to their patients. Id. at 53-54. However, the
constitutionality of the Harrison Act was upheld in Nigro v. United States. 276 U.S. 332
(1928).
59 DRUGS AND DRUG POLICY IN AMERICA, supra note 31, at 130. The pharmaceutical and
medical professions were also responsible for having marijuana dropped from the Harrison
Act of 1914, prior to its adoption. SLOMAN, supra note 35, at 36.
60 SLOMAN, supra note 35, at 75. Dr. Woodward was both an attorney and a physician
who served as counsel for the American Medical Association. GRINSPOON & BAKALAR,
supra note 1, at 9.
61 GRISPOON & BAKALAR, supra note 1, at 9. As to the addictive qualities of marijuana to
which others had testified, Dr. Woodward noted:
The newspapers have called attention to it so prominently that there
must be some grounds for their statements. It has surprised me,
however, that the facts on which these statements have been based
have not been brought before this committee by competent primary
evidence. We are referred to newspaper publications concerning the
prevalence of marihuana addiction. We are told that the use of
marihuana causes crime.
But as yet no one has been produced from the Bureau of Prisons
to show the number of prisoners who have been found addicted to the
marihuana habit. An informal inquiry shows that the Bureau of
Prisons has no evidence on that point.
You have been told that school children are great users of
marihuana cigarettes. No one has been summoned from the
Children's Bureau to show the nature and extent of the habit among
children.
Inquiry of the Children's Bureau shows that they have had no
occasion to investigate it and know nothing particularly of it.
Inquiry of the Office of Education-and they certainly should
know something of the prevalence of the habit among the school
children of the country, if there is a prevalence of the habit-indicates
that they have had no occasion to investigate and know nothing of it.
Hearing on H.R. 6385: Taxation of Marihuana, 75th Cong. 91, 94 (1937) (statement of Dr.
William C. Woodward), reprinted in GRINSPOON & BAKALAR, supra note 1, at 9.
62 SLOMAN, supra note 35, at 75-76.
63 BONNIE & WHITEBREAD II, supra note 40, at 164-65.
64 Id.
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his position on the proposal, Dr. Woodward was subjected to a very
critical and unmerciful examination by the committee conducting the
hearings.65
Despite the objections of Dr. Woodward and the American Medical
Association, Congress enacted the Marijuana Tax Act.66 The Marijuana
Tax Act was modeled after a prior taxation scheme that involved a tax on
machine guns.67 Though the Marijuana Tax Act was offered as a
revenue-raising measure, the actual effect was that of a prohibitive tax.68
While the tax levied on marijuana for medicinal use was set at a lower
rate, the tax for other uses was set so extraordinarily high that those
wishing to use marijuana for nonmedicinal use would be forced to
purchase the drug through illegal means.69 Therefore, the possessor of
the unregistered marijuana would be subjected to the possibility of
prosecution for tax evasion. 70 The Marijuana Tax Act also had a
secondary effect of making legitimate medicinal marijuana increasingly
difficult to obtain, as physicians often did not have any desire to deal
with all of the bureaucratic red tape that accompanied the registration
procedures. 71
65 Id. at 170-72. In particular, Robert Doughton, the Chairman of the Ways and Means
Committee, levied the following condemnation of Dr. Woodward's testimony following his
unappreciated answers to some of the Chairman's questions:
If you want to advise us on legislation, you ought to come here with
some constructive proposals, rather than criticism, rather than trying
to throw obstacles in the way of something that the Federal
Government is trying to do. It has not only an unselfish motive in this,
but they have a serious responsibility.
Id. at 172.
66 See supra note 57 and accompanying text.
67 BONNIE & WHITEBREAD II, supra note 40, at 124-25. The National Firearms Act allowed
for the purchase of machine guns. Id. However, the tax was not merely a revenue-raising
scheme because the tax was set so high so as to make the purchase price prohibitive to an
actual purchase. Id. The constitutionality of this Act was upheld by the United States
Supreme Court. Sonzinsky v. United States, 300 U.S. 506 (1937).
68 GRINSPOON, supra note 29, at 20.
69 Id. at 21.
70 Id.; see also United States v. Sanchez, 340 U.S. 42, 43-44 (1950) (discussing how the
Marijuana Tax Act operated and discussing its purposes); Marcia Teirsky, Comment,
Medical Marijuana: Putting the Power Where it Belongs, 93 NW. U. L. REV. 547, 549 (1999)
(noting that the penalty for possession of marijuana without payment of the tax carried the
penalties of five years in prison and a fine of $2,000).
7 See Raymond J. Walsh, Jr., Populations at Risk for Criminal Liability Under Compassionate
Use Acts, 25 NEW ENG. J. ON CRIM. & CIV. CONFINEMENT 275, 280 (1999).
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The Marijuana Tax Act remained viable until challenged by Dr.
Timothy Leary. 72 Dr. Leary attempted to cross the border into Mexico,
but he was denied entry and told to turn around. 73 He reentered the
customs stop on the American side, and his car was searched,
whereupon, marijuana was found.74  Dr. Leary was arrested for
marijuana smuggling when it was discovered that he had not paid the
transfer tax pursuant to the Marijuana Tax Act.75 Dr. Leary challenged
the constitutionality of the Marijuana Tax Act by averring that it violated
his Fifth Amendment right against self-incrimination and that the
statutory presumption that mere possession of marijuana was sufficient
evidence that the accused knew that the marijuana had been illegally
imported violated his due process rights.76 The Supreme Court agreed
with Dr. Leary, and the Court subsequently reversed both of his
convictions under the Marijuana Tax Act. 77 Congress wasted little time
in reacting to the holding in Leary v. United States.78
72 Leary v. United States, 395 U.S. 6 (1969). Dr. Leary was a professor of psychology at
Harvard University's Center for Research in Human Personality. DRUGS AND DRUG POLICY
IN AMERICA, supra note 31, at 271-72. It was there that Dr. Leary conducted research on
LSD. Id. Dr. Leary was later fired from Harvard because he had become a very vocal
proponent of the use of LSD and other psychedelic drugs. Id.
73 Leary, 395 U.S. at 10; see also Bergstrom, supra note 36, at 159-60 (providing further
examination of Timothy Leary's case).
74 Leary, 395 U.S. at 10.
75 Id. at 11.
76 Id. at 12.
77 Id. at 29, 52-53. The Court noted that there had never been a nonregistrant who had
applied to prepay the transfer tax. Id. at 25. In ruling on the self-incrimination theory, the
Court reasoned that, because Dr. Leary was faced with a regulatory scheme that required
the divulgence of incriminating information and that it, in effect, did not actually allow for
him to acquire any marijuana, he could not be held criminally liable for the noncompliance.
Id. at 26, 29. As to Dr. Leary's due process claim, the Court noted that, because of the way
that marijuana was both imported and grown domestically, it could not be more likely than
not that a possessor would know of the origin of his marijuana. Id. at 46-47. Indeed, such a
presumption was "no more than speculation." Id. at 52-53. However, the Court found it
necessary to add "that nothing in what we hold today implies any constitutional disability
in Congress to deal with the marihuana traffic by other means." Id. at 54. The United
States Supreme Court has similarly invalidated a state taxation scheme that was used in
marijuana prosecutions in the state of Montana. Dep't of Revenue of Mont. v. Kurth
Ranch, 511 U.S. 767, 784 (1994). In Kurth Ranch, a family was arrested for the cultivation
and sale of marijuana on its family farm. Id. at 771. The state law provided for the
collection of taxes on illegal drugs after the initial prosecution for the criminal charges of
cultivation and sale of marijuana. Id. at 770-77. The Court found that the purpose and
application of the law were inconsistent with normal revenue-raising taxation schemes
and, as such, could be fairly characterized as a punitive measure. Id. at 783. While the
Court noted that taxes for deterring activities may be valid, the particular application of
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The following year, Congress enacted the Controlled Substances Act
of 1970.79 The Controlled Substances Act effected a consolidation of
existing federal laws.80 Contained within the Controlled Substances Act
was the Comprehensive Drug Abuse Prevention and Control Act.81 The
significance of the Comprehensive Drug Abuse Prevention and Control
Act is that it establishes a scheduling of drugs with regard to their
medical usefulness as well as their potential for abuse.8 2 Marijuana is
included in Schedule I, which is the most restrictive classification
contained in the Act.8 3 As a controlled substance under Schedule I,
this tax was punitive. Id. The Court held that, because of its punitive character, the tax
could not be assessed following a criminal conviction, as this would violate the Double
Jeopardy Clause contained in the Fifth Amendment. Id. at 784. The Court reasoned that
the tax "was the functional equivalent of a successive criminal prosecution that placed the
Kurths in jeopardy a second time for the same offense." Id. However, the Court did note
that such a tax could constitutionally be levied at the same time as the original prosecution.
Id.
78 395 U.S. 6; see infra notes 79-87 and accompanying text.
79 21 U.S.C. § 801 (2000). The United States Supreme Court has recognized that
§841(a)(1) of the Controlled Substances Act makes it unlawful to knowingly or
intentionally manufacture, distribute, dispense, or possess a controlled substance with the
intention of manufacturing, distributing, or dispensing the controlled substance. United
States v. Oakland Cannabis Buyers' Coop., 532 U.S. 483, 490 (2001). The Controlled
Substances Act does provide an exception for research projects that are approved by the
Attorney General. 21 U.S.C. § 823(f) (2000). But see infra note 87 and accompanying text.
80 DRUGS AND DRUG POLICY IN AMERICA, supra note 31, at 278; see also Abbie Crites-
Leoni, Comment, Medicinal Use of Marijuana: Is the Debate a Smoke Screen for Movement
Toward Legalization, 19 J. LEGAL MED. 273, 275 (1998) (noting that Title 21 incorporated the
Controlled Substances Act, the Controlled Substances Import and Export Act, and
borrowed from the Uniform Controlled Substances Act).
81 Pub. L. No. 91-513, 84 Stat. 1236 (1970).
82 DRUGS AND DRUG POLICY IN AMERICA, supra note 31, at 278; see also infra note 83.
83 21 U.S.C. § 812 (2000). This section provides five schedules of controlled substances.
Id. Each schedule requires certain findings regarding the particular drug for it to be placed
into the particular schedule. Id. The requirements are as follows:
(1) SCHEDULE I-
(A) The drug or other substance has a high potential for
abuse.
(B) The drug or other substance has no currently accepted
medical use in treatment in the United States.
(C) There is a lack of accepted safety for use of the drug or
other substance under medical supervision.
(2) SCHEDULE II-
(A) The drug or other substance has a high potential for
abuse.
(B) The drug or other substance has a currently accepted
medical use in treatment in the United States or a currently
accepted medical use with severe restrictions.
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marijuana has been determined to have a high potential for abuse, no
currently accepted medicinal use for treatment, and, even under medical
supervision, a lack of acceptable safety for its use.84  An essential
difference between controlled substances under Schedule I and Schedule
II is that, unlike Schedule I drugs, those drugs that are classified under
(C) Abuse of the drug or other substances may lead to severe
psychological or physical dependence.
(3) SCHEDULE III-
(A) The drug or other substance has a potential for abuse
less than the drugs or other substances in schedules I and II.
(B) The drug or other substance has a currently accepted
medical use in treatment in the United States.
(C) Abuse of the drug or other substance may lead to
moderate or low physical dependence or high psychological
dependence.
(4) SCHEDULE IV-
(A) The drug or other substance has a low potential for
abuse relative to the drugs or other substances in
schedule III.
(B) The drug or other substance has a currently accepted
medical use in treatment in the United States.
(C) Abuse of the drug or other substance may lead to limited
physical dependence or psychological dependence relative
to the drugs or other substances in schedule III.
(5) SCHEDULE V-
(A) The drug or other substance has a low potential for
abuse relative to the drugs or other substances in
schedule IV.
(B) The drug or other substance has a currently accepted
medical use in treatment in the United States.
(C) Abuse of the drug or other substance may lead to limited
physical dependence or psychological dependence relative
to the drugs or other substances in schedule IV.
Id. Marijuana shares its position in Schedule I with other drugs such as heroin, LSD,
mescaline, and peyote, while other "innocuous" drugs, such as cocaine and opium, are
listed under the less restrictive Schedule II. Id. Also present in Schedule II is Marinol, a
synthetic form of the THC that is found naturally in marijuana. Nicole Dogwill, Comment,
The Burning Question: How Will the United States Deal with the Medical Marijuana Debate, 1998
DET. C.L. AT MICH. ST. U. L. REv. 247, 248 (1998). However, Marinol is generally seen as an
ineffective alternative to actual marijuana in a smokable form. See generally SLOMAN, supra
note 35, at 414; ZIMMER & MORGAN, supra note 29, at 16-25; Marsha N. Cohen, Comment,
Breaking the Federal/State Impasse Over Medical Marijuana: A Proposal, 11 HASTINGS WOMEN'S
L.J. 59, 71-72 (2000). The problem with the pill form of Marinol is that it is very difficult for
those with chemotherapy-induced nausea, for example, to swallow and digest anything,
much less a pill. ZIMMER & MORGAN, supra note 29, at 18. Additionally, smoked marijuana
provides the needed relief relatively quickly as opposed to Marinol, which takes over an
hour to provide the desired effects. Id. But see DRUG LEGALIZATION, supra note 35, at 154-55
(noting the concerns of using the smoked form of marijuana).
84 21 U.S.C. § 812(b)(1).
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Schedule II are defined as having a currently accepted medicinal use for
treatment.85 The Comprehensive Drug Abuse Prevention and Control
Act vests the United States Attorney General with the authority to
classify a particular substance to be controlled into a schedule.86 In
85 Id. Interestingly enough, when the states have passed marijuana legislation, they
consistently refer to the beneficial effects of marijuana in alleviating pain and suffering for
such afflictions as chemotherapy-induced nausea, AIDS wasting syndrome, and muscle
spasticity disorders. See infra note 90. By and large, the American public understands the
usefulness of medicinal marijuana, as can be evidenced from a poll conducted by the
American Civil Liberties Union, in which 79% of those polled agreed that a doctor should
be able to prescribe marijuana for pain relief and other medical uses. ZIMMER & MORGAN,
supra note 29, at 134. With regard to the safety of marijuana, studies have shown that
"[t]here is no possibility of a fatal overdose from smoking marijuana, regardless of THC
content." Id. at 139.
86 21 U.S.C. § 811(a) (2000). This section of the Comprehensive Drug Abuse Prevention
and Control Act provides:
The Attorney General shall apply the provisions of this subchapter to
the controlled substances listed in the schedules established by section
812 of this title and to any other drug or other substance added to such
schedules under this subchapter. Except as provided in subsections
(d) and (e) of this section, the Attorney General may by rule-
(1) add to such a schedule or transfer between such
schedules any drug or other substance if he-
(A) finds that such drug or other substance has a
potential for abuse, and
(B) makes with respect to such drug or other
substance the findings prescribed by subsection
(b) of section 812 of this title for the schedule in
which such drug is to be placed; or
(2) remove any drug or other substance from the
schedules if he finds that the drug or other substance
does not meet the requirements for inclusion in any
schedule.
Id. The Act also provides for the ability of the Attorney General to transfer drugs into a
different schedule. Id. Before the Attorney General can transfer drugs to another schedule,
the Act provides that he or she must make an evaluation of the drug, whereby:
The Attorney General shall, before initiating proceedings under
subsection (a) of this section to control a drug or other substance or to
remove a drug or other substance entirely from the schedules, and
after gathering the necessary data, request from the Secretary a
scientific and medical evaluation, and his recommendations, as to
whether such drug or other substance should be so controlled or
removed as a controlled substance. In making such evaluation and
recommendations, the Secretary shall consider the factors listed in
paragraphs (2), (3), (6), (7), and (8) of subsection (c) of this section and
any scientific or medical considerations involved in paragraphs (1), (4),
and (5) of such subsection. The recommendations of the Secretary
shall include recommendations with respect to the appropriate
schedule, if any, under which such drug or other substance should be
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considering the rescheduling of marijuana, the ability of the Attorney
General to gather new evidence regarding the medicinal value of
marijuana has been diminished by Congress' reluctance to allow further
medicinal marijuana studies.8 7
listed. The evaluation and the recommendations of the Secretary shall
be made in writing and submitted to the Attorney General within a
reasonable time. The recommendations of the Secretary to the
Attorney General shall be binding on the Attorney General as to such
scientific and medical matters, and if the Secretary recommends that a
drug or other substance not be controlled, the Attorney General shall
not control the drug or other substance. If the Attorney General
determines that these facts and all other relevant data constitute
substantial evidence of potential for abuse such as to warrant control
or substantial evidence that the drug or other substance should be
removed entirely from the schedules, he shall initiate proceedings for
control or removal, as the case may be, under subsection (a) of this
section.
Id. § 811(b). Prior to control or removal of a drug from the schedules, the Attorney General
is required to consider the following factors:
(1) Its actual or relative potential for abuse.
(2) Scientific evidence of its pharmacological effect, if known.
(3) The state of current scientific knowledge regarding the drug or
other substance.
(4) Its history and current pattern of abuse.
(5) The scope, duration and significance of abuse.
(6) What, if any, risk there is to the public health.
(7) Its psychic or psychological dependence liability.
(8) Whether the substance is an immediate precursor of a substance
already controlled under this subchapter.
Id. § 811(c); see United States v. Oakland Cannabis Buyers' Coop., 532 U.S. 483, 492-93
(2001). The Cooperative argued against the validity of marijuana's classification into
Schedule I because it was Congress, rather than the Attorney General, who had determined
marijuana's classification. Oakland Cannabis Buyers' Coop., 532 U.S. at 492-93. However, the
Court rejected the argument because the Court found no reason to treat drugs differently
based on who classifies them. Id.
87 DRUG LEGALIZATION, supra note 35, at 155. While medicinal marijuana studies had
been halted for some time, the U.S. Food and Drug Administration has recently approved a
clinical study of the drug MDMA, more commonly known Ecstasy. Rachel Zimmerman,
FDA Permits Test of Ecstasy as Aid in Stress Disorder, WALL ST. J., Nov. 6, 2001, at B1. The
study is designed to test the usage of MDMA in treatment for Post-Traumatic Stress
Disorder ("PTSD"), the incidence of which the proponents of the study feel will continue to
increase following the terrorist attacks of September 11, 2001. Id. What is interesting about
the FDA approval of this study is that MDMA is classified into Schedule I along with
marijuana. Id. This is especially true in light of the fact that there were thirteen deaths in
1999 alone attributed to MDMA, while studies show that no dose of marijuana would be
fatal. Id.; see also ZIMMER & MORGAN, supra note 29, at 8. However, the aversion to
medicinal marijuana studies may be changing, as the Drug Enforcement Agency recently
granted approval for marijuana study at the University of California at San Diego.
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C. Attempts to Effectuate Change in the System
1. State-Based Initiatives
The states and their citizens have responded to the federal
government's classification of marijuana into Schedule I by enacting
initiatives allowing for the use of medicinal marijuana under the relevant
state laws. 88 California and Arizona have led this movement by enacting
laws allowing the use of medicinal marijuana in 1996.89 Numerous other
states have followed their example by enacting their own versions of
medicinal marijuana reforms.90 Significantly, current President George
Associated Press, UCSD to Conduct Medical Marijuana Study, at http://www.cnn.com/
2001/HEALTH/11/29/medical.marijuana.ap/index.html (last visited Dec. 30, 2001).
88 See, e.g., Cohen, supra note 83, at 66; Alreen Hussein, Comment, The Growing Debate on
Medical Marijuana: Federal Power vs. States Rights, 37 CAL. W. L. REV. 369, 378 (2001).
89 California's law was a direct result of the voter support of Proposition 215. CAL.
HEALTH & SAFETY CODE § 11362.5 (West Supp. 2002). It is known as the Compassionate
Use Act of 1996. Id. The text of the Act emphasizes the concern for the unfortunately large
number of AIDS patients in the state. Id. Arizona voters adopted Proposition 200 in
November 1996. ARiz. REV. STAT. ANN. § 13-3412.01 (West 2001); see also Dogwill, supra
note 83, at 247. But see Matthew Segal, Comment, Overdue Process: Why Denial of Physician-
Prescribed Marijuana to Terminally Ill Patients Violates the United States Constitution, 22
SEATTLE U. L. REV. 235, 263 n.5 (1998) (noting that the Arizona legislature revised the
voters' initiative by making medicinal marijuana legalization dependent upon federal
legalization).
90 See ALASKA STAT. §§ 11.71.090, 17.37.010-17.37.080 (Michie 2000); see also COLO. CONST.
art. XVIII, § 14. Colorado allowed the "medical use of marijuana for persons suffering from
debilitating medical conditions" including cancer, glaucoma, AIDS, severe pain, nausea,
seizures, epilepsy, and multiple sclerosis. COLO. CONST. art. XVIII, § 14. The Hawaii
statute allowed for an "adequate supply" of marijuana that is
not more than is reasonably necessary to assure the uninterrupted
availability of marijuana for the purpose of alleviating the symptoms
or effects of a qualifying patient's debilitating medical condition;
provided that an 'adequate supply' shall not exceed three mature
marijuana plants, four immature marijuana plants, and one ounce of
usable marijuana per each mature plant.
HAW. REV. STAT. § 329-121 (Supp. 2001). The medical conditions recognized for marijuana
treatment include cancer, glaucoma, AIDS, severe pain and nausea, seizures, and muscle
spasms. Id. The Maine statute authorized possession for
a person to whom or for whose use any scheduled drug, prescription
drug or controlled substance has been prescribed, sold or dispensed
for a legitimate medical purpose by a physician, dentist, podiatrist,
pharmacist or other person acting in the usual course of professional
practice and authorized by law or rule to do so ....
ME. REV. STAT. ANN. tit. 22, § 2383-B (West Supp. 2001). The statute recognized marijuana
as treatment for nausea, vomiting, wasting syndrome or loss of appetite as a result of AIDS,
chemotherapy, glaucoma, seizures, and muscle spasms. Id.; see also NEV. CONST. art. IV,
§ 38 (allowing marijuana to be prescribed for treatment of cancer, glaucoma, AIDS, nausea,
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W. Bush has gone on record in support of states' rights to determine for
themselves how to address this issue.91  Moreover, Representative
Barney Frank, a Democrat from Massachusetts, has introduced a
proposal into the United States House of Representatives that calls for
the rescheduling of marijuana from Schedule I to Schedule 11.92
epilepsy, seizures, and multiple sclerosis); OR. REV. STAT. § 475.300 (2001). The Oregon
statute provided:
The people of the state of Oregon hereby find that:
(1) Patients and doctors have found marijuana to be an effective
treatment for suffering caused by debilitating medical conditions, and
therefore, marijuana should be treated like other medicines;
(2) Oregonians suffering from debilitating medical conditions should
be allowed to use small amounts of marijuana without fear of civil or
criminal penalties when their doctors advise that such use may
provide a medical benefit to them.
OR. REV. STAT. § 475.300. The Washington statute provided:
The People of Washington state find that some patients with terminal
or debilitating illnesses, under their physician's care, may benefit from
the medical use of marijuana. Some of the illnesses for which
marijuana appears to be beneficial include chemotherapy-related
nausea and vomiting in cancer patients; AIDS wasting syndrome;
severe muscle spasms associated with multiple sclerosis and other
spasticity disorders; epilepsy; acute or chronic glaucoma; and some
forms of intractable pain.
The People find that humanitarian compassion necessitates that
the decision to authorize the medical use of marijuana by patients with
terminal or debilitating illnesses is a personal, individual decision,
based upon their physician's professional medical judgment and
discretion.
WASH. REV. CODE ANN. § 69.51A.005 (West Supp. 2002).
91 Susan Feeney, Bush Backs States' Rights on Marijuana: He Opposes Medical Use But
Favors Local Control, DALLAS MORNING NEWS, Oct. 20, 1999, at 6A. Then Governor of Texas,
Mr. Bush stated, "I believe each state can choose that decision as they so choose." Id.
92 H.R. 2592, 107th Cong. (2001). The avowed purpose of the Bill is "[t]o provide for the
medical use of marijuana in accordance with the laws of the various States." Id. The Bill
includes thirteen co-sponsors from both political parties. Id. The Bill provides:
No provision of the Controlled Substances Act [or] ... the Federal
Food, Drug, and Cosmetic Act shall prohibit or otherwise restrict:
(A) the prescription or recommendation of marijuana by a
physician for medical use,
(B) an individual from obtaining and using marijuana from a
prescription or recommendation of marijuana by a physician for
medical use by such individual, or
(C) a pharmacy from obtaining and holding marijuana for the
prescription or recommendation of marijuana by a physician for
medical use under applicable State law.
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However, many Americans remain opposed to the idea of allowing
marijuana to be prescribed as medicine. Many fear that marijuana acts
as a gateway drug to more serious drugs, such as heroin or cocaine. 93
Others are concerned with the possible deleterious physiological effects
that result from the usage of marijuana. 94 Similarly, those opposed to
medicinal marijuana note the increase in drug use by teenagers, the
increase in marijuana-related emergency room visits, and the increase in
the numbers of babies born addicted to drugs.95
Critics of medicinal marijuana also point to the costs of marijuana on
society as a whole. First, the illegal drug trade has had a negative impact
on the natural environment. 96 Secondly, there is a concern about the
possibility of increased accidents in the workplace that would be caused
by marijuana users.97 Thirdly, many fear that if any of the restrictions on
marijuana are reduced the result would be an increase in crime.98
Similarly, those opposed have noted that, because of such an increase in
crime, many doctors would refuse to prescribe medicinal marijuana
simply because they would not want to be associated with any
perception of criminal activity. 99 The concerns of those opposed to
medicinal marijuana are valid, and, as such, any proposal for change
would need to address these concerns properly in order to maintain any
semblance of legitimacy. 1°°
93 HANSON ET AL., supra note 32, at 387.
94 Id. at 377-78 (noting that marijuana, when smoked, can have negative effects on the
central nervous system, the respiratory system, and the cardiovascular system); see also
GARY J. MILLER, DRUGS AND THE LAW: DETECTION, RECOGNITION, AND INVESTIGATION 409-
11 (1992) (discussing marijuana use by pregnant women and the correlation to lower infant
birth weight).
95 HANSON ET AL., supra note 32, at 368-69. Between 1991 and 1995, marijuana use by
twelfth-graders rose from 29.9% to 34% in the United States. Id. at 368. Furthermore,
marijuana and hashish-related emergency room visits rose 39% from 1993 to 1994. Id. at
369; see also MILLER, supra note 94, at 4, 409 (noting a study conducted in Oregon in which
29% of all infants born addicted to drugs were affected by marijuana).
96 MILLER, supra note 94, at 6-7 (discussing the use of poisons and rodenticides by
clandestine growers in remote areas, which pollute waterways and underground streams).
97 Id. at 6 (discussing the dangers to which drug-impaired employees expose themselves
and co-workers by being impaired while at work).
98 Id. at 7-8 (noting that nearly half of all federal prisoners in 1990 were convicted for
drug offenses).
99 Id. at 488.
100 See infra notes 199-210 and accompanying text.
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2. Lobbying Groups and the Courts
Over the years, lobbying groups such as the National Organization
for the Reform of Marijuana Laws ("NORML") and the Alliance for
Cannabis Therapeutics have attempted to use the judicial system to
change the application of marijuana laws in the United States.10 1 In one
case, NORML sought to have marijuana removed entirely from the
Controlled Substances Act or to at least have marijuana reclassified from
Schedule I to Schedule V.102 The Director of the Bureau of Narcotics and
Dangerous Drugs, under a delegation of authority from the Attorney
General, refused NORML's request. 103 NORML then brought suit
challenging the Director's ruling.1°4 The court held that the Attorney
General was within his authority to refuse NORML's request. 05
In a later proceeding involving the same parties, the determination
of the Administrator of the Drug Enforcement Agency that marijuana
had no currently accepted medical use was challenged. 10 6 The court
found the Administrator's interpretation of the statute to be a reasonable
one.10 7 As of yet, these lobbying groups have been unsuccessful in their
101 See, e.g., Alliance for Cannabis Therapeutics v. Drug Enforcement Admin., 15 F.3d
1131 (D.C. Cir. 1994); Alliance for Cannabis Therapeutics v. Drug Enforcement Admin., 930
F.2d 936 (D.C. Cir. 1991); Nat'l Org. for the Reform of Marijuana Laws v. Drug Enforcement
Admin., 559 F.2d 735 (D.C. Cir. 1977).
102 Nat'l Org. for the Reform of Marijuana Laws, 559 F.2d at 741.
103 Id. The Director's reason for not granting the National Organziation for the Reform of
Marijuana Laws' ("NORML") request was that he felt that any reclassification would
violate the Single Convention. Id. The Single Convention was a proposal by the United
Nations in 1948 to create a uniform set of rules regarding the international traffic of
narcotics; the United States signed the Convention in 1967. Id. at 739.
104 Id. at 743.
105 Id. at 752. Interestingly, the court concluded that separated marijuana leaves could be
transferred to Schedule V consistent with the Single Convention. Id. at 753; see also supra
note 103. The Acting Administrator had refused to transfer marijuana leaves, which the
court found to be a premature decision as he had not consulted with the Department of
Health, Education, and Welfare prior to making his decision. Nat'l Org. for the Reform of
Marijuana Laws, 559 F.2d at 754.
106 Alliance for Cannabis Therapeutics, 930 F.2d at 937. The Administrator found that only a
"respectable minority" of physicians adhered to the use of marijuana as medical treatment.
Id. at 938. The Administrator ruled that this "respectable minority" was not conclusory
evidence to show that there was a currently accepted medicinal use for marijuana. Id.
107 Id. at 939. The court seemed obliged to defer to the Administrator's finding based on
its interpretation of the Supreme Court's decision in Chevron U.S.A., Inc. v. Natural Resource
Defense Council, Inc., 467 U.S. 837, 843-45 (1984). Id. The court did, however, remand the
case because the Administrator had based his decision on an eight-factor test, of which
three of the factors were found to be unrealizable and, therefore, arbitrary and capricious.
Id. at 940-41. After the remand, the Administrator again refused to reschedule marijuana
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attempts to use the court system to have marijuana reclassified into a
lower schedule under the Controlled Substances Act.108  Because
marijuana remains classified in Schedule I, those who are arrested must
rely on other novel approaches, including the First Amendment and the
medical necessity defense, in order to attempt to prevent their criminal
prosecution under the current state of the law.
3. The Free Exercise of Religion Clause
Numerous plaintiffs have challenged their convictions for drug
possession by asserting their right to free exercise of religion under the
First Amendment. 1°9 However, the free exercise defense has only been
recognized when the drug involved was sacramental peyote used by the
Native American Church.110 The Ethiopian Zion Coptic Church ("the
Church") has sought an exemption for the use of marijuana for religious
purposes."' The teachings of the Church involve the continual use of
without the objectionable factors, and his decision was again appealed. Alliance for
Cannabis Therapeutics v. Drug Enforcement Admin., 15 F.3d 1131 (D.C. Cir. 1994). The
court held that the Administrator's new five-factor test met its objections and, as a result,
again deferred to his interpretation by noting that the findings were supported by
substantial evidence. Id. at 1135, 1137. The five-factor test formulated by the Administrator
for determining whether a drug is currently accepted in medicinal use includes: (1) the
drug's chemistry must be known and reproducible; (2) there must be adequate safety
studies; (3) there must be adequate and well-controlled studies proving efficacy; (4) the
drug must be accepted by qualified experts; and (5) the scientific evidence must be widely
available. Id. at 1135. The court went on to note that "[nione of these criteria is impossible
for a Schedule I drug to meet." Id.
108 See, e.g., Alliance for Cannabis Therapeutics, 15 F.3d 1131; Alliance for Cannabis
Therapeutics, 930 F.2d 936; Nat'l Org. for the Reform of Marijuana Laws, 559 F.2d 735.
109 Employment Div., Dep't of Human Res. of Or. v. Smith, 494 U.S. 872, 917 n.8 (1990)
(Blackmun, J., dissenting) (providing a list of cases in which a free exercise exemption was
invoked as an affirmative defense and, as to marijuana, was denied). In Smith, the United
States Supreme Court ruled that Oregon, consistent with the Free Exercise Clause, could
refuse to allow an exception for religious peyote use under state law even though the
federal government and other states do recognize the exception for religious peyote use.
Id. at 890.
110 Id. Both the federal government and eleven states recognize an exemption for the
religious use of sacramental peyote. Id. at 906. The religious use of peyote is most clearly
associated with the Native American Church. Id. Interestingly, under federal law, peyote
and marijuana are both classified into Schedule I under the Controlled Substances Act. 21
U.S.C. § 812 (2000). The Court in Smith noted a distinction between the religious use of
peyote and the religious use of other controlled substances, in that "[s]ome religious claims
•.. involve drugs such as marijuana and heroin, in which there is significant illegal traffic,
with its attendant greed and violence, so that it would be difficult to grant a religious
exemption without seriously compromising law enforcement efforts." Smith, 494 U.S. at
918.
1l Olsen v. Drug Enforcement Admin., 878 F.2d 1458, 1459 (D.C. Cir. 1989).
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marijuana throughout the day for its adherents." 2 In refusing to grant
such an exemption to the Church, then-Circuit Judge Ruth Bader
Ginsburg found the differences in demand between marijuana and
peyote to be a crucial factor. 113 It did seem to appear, however, that
Judge Ginsburg recognized some beneficial use of marijuana for
medicinal purposes." 4 To date, though, it does not appear that many
courts will be willing to grant a religious use exemption for marijuana." 5
4. The Medical Necessity Defense
The necessity defense has been characterized as a choice between
two evils.116 The necessity defense was created and recognized under
the common law. 117 Modem courts, however, have not been receptive to
the medical necessity defense when used as a defense for marijuana
possession." 8 One of the more significant difficulties defendants have
112 Id.
113 Id. at 1463-64. But see Smith, 494 U.S. at 918 (Blackmun, J., dissenting) (noting that the
Roman Catholic Church's use of sacramental wine was exempted from the ban on alcohol
during Prohibition).
114 Olsen, 878 F.2d at 1463 n.4. Judge Ginsburg noted that the "[g]overnment may allow
use of marijuana in programs to lessen the negative side-effects of chemotherapy and to
treat glaucoma ... without thereby opening the way to licenses for the use of marijuana by
the healthy." Id.
115 See supra note 109.
116 United States v. Bailey, 444 U.S. 394, 410 (1980) (noting that "the defense of necessity,
or choice of evils, traditionally covered the situation where physical forces beyond the
actor's control rendered illegal conduct the lesser of two evils").
117 State v. Hastings, 801 P.2d 563, 564 (Idaho 1990). In Hastings, the Idaho Supreme
Court held that Idaho law was not a bar to the use of the defense of necessity. Id. The
court remanded the case to allow a jury to consider the application of the necessity defense
to a woman who was arrested for possessing marijuana that she used to treat her
rheumatoid arthritis. Id. at 565. The court noted that
The elements of the common law defense of necessity are:
1. A specific threat of immediate harm;
2. The circumstances which necessitate the illegal act must not
have been brought about by the defendant;
3. The same objective could not have been accomplished by a less
offensive alternative available to the actor;
4. The harm caused was not disproportionate to the harm
avoided.
Id. at 564; see also George L. Blum, Annotation, Defense of Necessity, Duress, or Coercion in
Prosecution for Violation of State Narcotics Laws, 1 A.L.R. 5th 938 (1992).
118 See generally United States v. Burton, 894 F.2d 188, 191 (6th Cir. 1990) (holding that the
medical necessity defense was unavailable to a man suffering from glaucoma due to the
amount of marijuana that he possessed); Spillers v. State, 245 S.E.2d 54, 55 (Ga. Ct. App.
1978) (holding that the medical necessity defense was unavailable for marijuana possession
by a man suffering from rheumatoid arthritis); State v. Corrigan, 2001 WL 881394, at *2
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had in asserting this defense is that the courts appear to be hostile to the
idea that there are no alternatives available other than medicinal
marijuana.1 9  Another significant difficulty in asserting a necessity
defense for medical reasons is that marijuana remains classified as a
Schedule I controlled substance, which carries the presumption that it
has no medically accepted purpose or use.120
The United States Supreme Court recently handed down a decision
regarding the medicinal use of marijuana in United States v. Oakland
Cannabis Buyers' Cooperative.121 In reviewing the federal drug laws, the
Court found no implied medical necessity exception to the prohibition
on the manufacturing and distribution of medicinal marijuana as
established in the Controlled Substances Act.' 22 The Court did not,
however, rule on whether the same defense would be available for those
accused of possession of marijuana. 123 Many agree that the Supreme
(Minn. Ct. App. Aug. 7, 2001) (holding that the medical necessity defense was unavailable
for marijuana possession); State v. Tate, 505 A.2d 941, 942, 947 (N.J. 1986) (holding that the
medical necessity defense was unavailable to a quadriplegic who used marijuana); State v.
Piland, 293 S.E.2d 278, 280 (N.C. Ct. App. 1982) (holding that medical necessity defense
was unavailable to a physician who grew marijuana for his patients); State v. Poling, 531
S.E.2d 678, 684-85 (W. Va. 2000) (holding that the medical necessity defense was
unavailable to a woman who used marijuana to relieve symptoms resulting from multiple
sclerosis).
119 Tate, 505 A.2d at 942, 947 (noting the availability of alternative means in obtaining
medicinal marijuana, while the dissent argued that the program was too ineffective to be
considered a true alternative). Additionally, some courts have chosen to defer to the state
legislatures for determinations regarding a defense of medical necessity. See Corrigan, 2001
WL 881394, at *2 (noting that "the question whether possession should be viewed
differently is one for the legislature to address"); Poling, 531 S.E.2d at 685 ("The Legislature
has made no exception for medical use .... [W]e hold that medical necessity is unavailable
as an affirmative defense to a marijuana charge in West Virginia ...."). Judicial deference
to the legislature seems peculiar for a defense that has its origins in the common law
created by the courts. See supra note 117 and accompanying text.
120 Poling, 531 S.E.2d at 685 (holding that the state legislature had classified marijuana as
a Schedule I controlled substance without providing an exception for medicinal use).
121 532 U.S. 483 (2001).
122 Id. at 492-93. The Court noted that, while the Controlled Substances Act did not
specifically nullify such a defense, "its provisions leave no doubt that the defense is
unavailable." Id. at 491. The Court further noted that while prior decisions had considered
the possibility of a defense of necessity, they had not rejected the idea altogether. Id. at 490;
see United States v. Bailey, 444 U.S. 394, 410 (1980); see also Tate, 505 A.2d 941; State v.
Diana, 604 P.2d 1312 (Wash. Ct. App. 1979); Blum, supra note 117, at 938 (surveying state
court cases in which the medical necessity defense has been asserted).
123 Oakland Cannabis Buyers' Coop., 532 U.S. at 494-95. "For these reasons, we hold that
medical necessity is not a defense to manufacturing and distributing marijuana." Id.
(emphasis added).
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Court's decision will create additional litigation.124  Moreover,
disagreement on this issue will not subside without distinguishing the
proper role of states' rights and the regulatory power of the United
States Congress.
D. The Role of Federalism
Federalism refers to a system of government, like that of the United
States, in which governmental power is divided among a national
government and individual states.125  The result of this form of
government is a great variety in both procedural and substantive laws
and rights.126 The Framers of the United States Constitution saw this
balance of powers as necessary to avoid any risk of tyranny or abuse
from any one entity. 127 Because of their former relationship with
England, the Framers' biggest fear was an overpowering central
government.128 As a result, the Bill of Rights was intended to restrain the
central government provided for by the Federal Constitution. 129 The
Ninth and Tenth Amendments of the Bill of Rights reflect this in their
acknowledgment of the retention of rights in both the people and the
states. 130 Thus, citizens at this time looked to their state constitutions for
protection of their rights.131 However, the passage of the Fourteenth
Amendment established that Americans have a dual citizenship in both
124 John Gibeaut, The Grass May Still Be Greener, A.B.A. J., Oct. 2001, at 90. Indeed, Gerald
Uelman, the law professor who argued on behalf of the Oakland Cannabis Buyers'
Cooperative in front of the Supreme Court, was quoted as saying, "It didn't end the
litigation." Id. Professor Uelman took part in a panel discussion of recent legal and
legislative developments on the medicinal marijuana issue at the American Bar
Association's Annual Meeting. Id. The panelists agreed that, if the states continue their
efforts to get marijuana on state ballots, then Congress will eventually feel the pressure and
change the federal statutes. Id.
125 COURTS, LAW, AND JUDICIAL PROCESSES 1 (S. Sidney Ulmer ed., 1981); see also BLACK'S
LAW DICTIONARY 253 (6th ed. 1996) (defining federalism as "[tihe relationship and
distribution of power between the individual states and the national government").
126 COURTS, LAW, AND JUDICIAL PROCESSES, supra note 125, at 1.
127 Randy J. Holland, State Constitutions: Purpose and Function, 69 TEMP. L. REV. 989, 994
(1996).
12 Id. at 997.
129 Id.
130 U.S. CONST. amend. IX ("The enumeration in the Constitution, of certain rights, shall
not be construed to deny or disparage others retained by the people."); id. amend. X ("The
powers not delegated to the United States by the Constitution, nor prohibited by it to the
States, are reserved to the States respectively, or to the people.").
131 G. Alan Tarr, The New Judicial Federalism in Perspective, 72 NOTRE DAME L. REV. 1097,
1099 (1997).
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the United States and their individual states. 132  Moreover, the
Fourteenth Amendment also worked as a restriction on the states' power
to prevent them from infringing on the liberties that dual citizenship
provided. 133
After passage of the Fourteenth Amendment, the United States
Supreme Court began the process of selectively incorporating rights
guaranteed by the Bill of Rights into the Fourteenth Amendment, thus
making them applicable to the states.'3 This process of incorporation
was incremental, and, as a result, very few provisions of the Bill of
Rights became binding on the states.135 During the 1960s, however, the
Supreme Court became more active and extended nine provisions of the
Bill of Rights to the states.136 The result of this judicial activism was that
states now have become deeply involved in the application of federal
law.137 Many scholars have noted that this shift has been detrimental to
individuals who attempt to assert their rights under the United States
Constitution because state constitutions often provide more expansive
protections.138 Even the United States Supreme Court has recognized
this in Michigan v. Long.139
132 U.S. CONST. amend. XIV, § I ("All persons born or naturalized in the United States,
and subject to the jurisdiction thereof, are citizens of the United States and of the State
wherein they reside.").
133 Id. The Fourteenth Amendment further provides that
No State shall make or enforce any law which shall abridge the
privileges or immunities of citizens of the United States; nor shall any
State deprive any person of life, liberty, or property, without due
process of law; nor deny to any person within its jurisdiction the equal
protection of the laws.
Id. See also Holland, supra note 127, at 1003.
134 Holland, supra note 127, at 1002.
135 See, e.g., William J. Brennan, Jr., State Constitutions and the Protection of Individual Rights,
90 HARV. L. REV. 489,493 (1977).
136 Id. at 493-94. During the 1960s, provisions of the Fifth, Sixth, and Eighth Amendments
were made applicable to several states. Id.
137 Id.
138 See, e.g., id., at 493; Holland, supra note 127, at 1002; Randall T. Shepard, The Maturing
Nature of State Constitution Jurisprudence, 30 VAL. U. L. REV. 421, 453 (1996); Randall T.
Shepard, Second Wind for the Indiana Bill of Rights, 22 IND. L. REV. 575, 577 (1989); Tarr, supra
note 131, at 1099; G. Alan Tarr, Understanding State Constitutions, 65 TEMP. L. REV. 1169, 1170
(1992).
139 463 U.S. 1032, 1033 (1982) ("If the state court decision indicates clearly and expressly
that it is alternatively based on bona fide separate, adequate, and independent grounds,
this Court will not undertake to review the decision.").
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The states, however, are not unrestrained in their provision of rights
and protections. The states remain bound by the Supremacy Clause,
which requires state action to comply with laws passed by Congress and
with the interpretations of those laws by the United States Supreme
Court.140 Similarly, state courts are also bound by the Supremacy Clause
when exercising their discretion in fashioning equitable relief.1 41 It is this
delicate balance of powers which has led to the current stalemate
involving medicinal marijuana.
On occasion, the United States Supreme Court has determined that
Congress has overstepped its Commerce Clause powers and, thus, has
invalidated certain federal statutes.142 For many years, the Supreme
Court had been more deferential to congressional action.143 However,
recent decisions indicate that the Supreme Court has become more
aggressive in reviewing congressional action.144  In United States v.
140 U.S. CONST. art. VI, cl. 2. The Supremacy Clause provides:
This Constitution, and the Laws of the United States which shall be
made in Pursuance thereof; and all Treaties made, or which shall be
made, under the Authority of the United States, shall be the supreme
Law of the Land; and the Judges in every State shall be bound thereby,
any Thing in the Constitution or Laws of any State to the Contrary
notwithstanding.
Id.
141 United States v. Oakland Cannabis Buyers' Coop., 532 U.S. 483, 497 (2001) ("Courts of
equity cannot, in their discretion, reject the balance that Congress has struck in a statute.");
Tenn. Valley Auth. v. Hill, 437 U.S. 153, 194 (1978) ("Once Congress, exercising its
delegated powers, has decided the order of priorities in a given area, it is. . . for the courts
to enforce them when enforcement is sought.").
142 United States v. Morrison, 529 U.S. 598, 617 (2000) (holding § 13981 of the Violence
Against Women Act of 1994 unconstitutional); United States v. Lopez, 514 U.S. 549, 557-68
(1995) (holding § 922(q) of the Gun-Free School Zones Act of 1990 unconstitutional).
143 Lopez, 514 U.S. at 556-57 (analyzing Commerce Clause case precedent from 1937 to the
1990s); see also Wickard v. Filburn, 317 U.S. 111, 128 (1942) (upholding federal regulations
of wheat grown intrastate because the aggregate of such activity had a substantial effect on
interstate commerce).
144 See Morrison, 529 U.S. at 617. In Morrison, the Court assessed the constitutionality of
§ 13981 of the federal Violence Against Women Act of 1994. Id. at 604. Section 13981
provided a civil remedy for the victims of crimes of violence that were motivated by
gender. Id. at 605-06. The Court held that this provision could not stand as a proper
exercise of Commerce Clause power by Congress. Id. at 619. The Court reasoned that
"[tihe regulation and punishment of intrastate violence that is not directed at the
instrumentalities, channels, or goods involved in interstate commerce has always been the
province of the States." Id. at 618.; see also Lopez, 514 U.S. at 556-57. In Lopez, the Court
evaluated the conviction of a high school student under the Gun-Free School Zones Act of
1990. Lopez, 514 U.S. at 551. This Act made it a federal offense to knowingly possess a
firearm within 1000 feet of a school. Id. The Supreme Court affirmed the determination of
the Fifth Circuit Court of Appeals that Congress had exceeded its Commerce Clause
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Lopez, 145 the Court established a paradigm for reviewing federal statutes
based on Congress' Commerce Clause powers.146 The Court began by
noting three broad categories of activity that Congress is permitted to
regulate. 4 7 The three categories include: first, the use of the channels of
interstate commerce; second, the instrumentalities of interstate
commerce, or persons or things in interstate commerce; and third,
economic activities that substantially affect interstate commerce. 148
The Court has determined that congressional action must contain a
jurisdictional element in order to show some nexus between the activity
to be regulated and interstate commerce. 149  Furthermore, it was also
determined that legislative findings regarding the effects that the
regulated activity has on interstate commerce would be relevant.15° The
Court noted that, while formal findings are normally not required, they
would assist in evaluating the constitutionality of congressional action.151
Subsequently, the Court has established that it is within this framework
authority. Id. at 552. One of the Court's reasons for doing so was that § 922(q) of the Act
was a criminal statute that failed to regulate an activity that had any substantial affect on
interstate commerce. Id. at 561.
145 Lopez, 514 U.S. at 561.
146 Id. at 559-63.
147 Id. at 558.
148 See, e.g., Morrison, 529 U.S. at 613 ("Gender-motivated crimes of violence are not, in
any sense of the phrase, economic activity."); Lopez, 514 U.S. at 558-61 (holding that the
statute regulating possession of guns in a school zone was "a criminal statute that by its
terms has nothing to do with commerce or any sort of economic enterprise, however
broadly one might define those terms").
149 See, e.g., Morrison, 529 U.S. at 613 (noting that § 13981 "contains no jurisdictional
element establishing that the federal cause of action is in pursuance of Congress' power to
regulate interstate commerce"); Lopez, 514 U.S. at 562 (noting that § 922(q) "has no express
jurisdictional element which might limit its reach to a discrete set of firearm possessions
that additionally have an explicit connection with or effect on interstate commerce").
150 Morrison, 529 U.S. at 617. In Morrison, the Court was faced with numerous findings on
the impact of gender-motivated violence on the victims and their families. Id. at 614.
However, the Court noted that "the existence of congressional findings is not sufficient, by
itself, to sustain the constitutionality of Commerce Clause legislation." Id.; see also Lopez,
514 U.S. at 563. In Lopez, the statute contained no express findings to correlate gun
possession in a school zone and any effects it may have had on interstate commerce. Lopez,
514 U.S. at 562. Rather, the government had sought to rely on previous findings in prior
federal enactments. Id. at 563. The Court found this reliance to be inappropriate because
the prior findings did not address the same subject matter. Id. Nor did the prior findings
establish any relationship of the statute at issue to interstate commerce. Id.
151 Lopez, 514 U.S. at 562-63 (noting that, "to the extent that congressional findings would
enable us to evaluate the legislative judgment that the activity in question substantially
affected interstate commerce, even though no such substantial effect was visible to the
naked eye, they are lacking here").
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that it will review legislative enactments. 52 However, the Court did
assert that it will not invalidate such enactments unless Congress has
clearly exceeded its constitutional bounds. 53
Some commentators have asserted that Congress has exceeded its
constitutional boundaries under the Commerce Clause by enacting the
Controlled Substances Act. 154  However, an investigation of the
Controlled Substances Act within the framework established by Lopez
will demonstrate that Congress has not exceeded its power, but rather
that Congress has wrongfully exercised its power. 155 As a result, a new
approach must be considered in order to effectuate any changes in
medicinal marijuana policy at the federal level.15 6
III. AN ANALYSIS OF THE ATTENDANT PROBLEMS ASSOCIATED WITH
CURRENT FEDERAL LAW REGARDING MEDICINAL MARIJUANA
A. Federalism and Medicinal Marijuana
Under the current federal laws and the analytical framework
established by the United States Supreme Court, it becomes apparent
that the federal government has the power to control this issue.157 While
many states have indicated their desire to be able to allow for medicinal
marijuana, it is the federal government that is preventing them from
doing so.158 The Supreme Court has held that Congress may regulate
economic activities that substantially affect interstate commerce. l5 9
Unlike the statutes involved in Lopez and Morrison that did not
regulate activities with any economic effects on interstate commerce,
152 Morrison, 529 U.S. at 608-09.
153 Id. at 607.
154 See, e.g., Hussein, supra note 88, at 384-93; Erik R. Neusch, Comment, Medical
Marijuana's Fate in the Aftermath of the Supreme Court's New Commerce Clause Jurisprudence, 72
U. COLO. L. REV. 201, 201 (2001). Both of these articles take the position that Congress has
exceeded its Commerce Clause powers because the Controlled Substances Act regulates
mere possession and compare it to the statute at issue in Lopez. However, this argument
fails to account for the fact that the marijuana must have come from elsewhere before a
person could be in "mere possession." See discussion infra Part III.A.
155 See infra notes 159-69 and accompanying text.
156 See infra Part IV.
157 See supra notes 83, 148-50 and accompanying text.
158 See supra notes 89-90, 121 and accompanying text.
159 United States v. Lopez, 514 U.S. 549, 559 (1995); see also supra note 148 and
accompanying text.
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marijuana does have an impact on interstate commerce. 160 In order to
see this impact, one can look to the amount of money expended in the
enforcement of drug laws. For example, in 1983 the federal budget
allocated approximately two billion dollars to the war on drugs, but by
1993 that number had increased to nearly thirteen billion dollars.'61
Moreover, those who would be responsible for prescribing,
manufacturing, and distributing medicinal marijuana would be making
profits on a substance that has an established market.162 Thus, marijuana
regulation can be seen as more akin to the regulation of the wheat
market that was upheld in Wickard v. Filburn.163
The next steps in the Lopez analysis look to the statute to find a
jurisdictional element and indications of congressional findings.164 The
Controlled Substances Act provides for both of these items in the text of
the Act. 165 The jurisdictional element can be satisfied by noting the flow
160 Lopez, 514 U.S. at 564; see also United States v. Morrison, 529 U.S. 598, 607 (2000); see
also supra note 148 and accompanying text.
161 MIKE GRAY, DRUG CRAZY 201 (1998). Similarly, the state and federal prison
population increased from 528,945 in 1986 to 1,987,110 in 1996. Id. Of those incarcerated,
over 400,000 had been convicted for drug law violations. DRUG LEGALIZATION, supra note
35, at 96.
162 See infra note 220 and accompanying text.
163 317 U.S. 111, 128 (1942); see supra note 143.
164 See supra notes 149-51 and accompanying text.
165 21 U.S.C. § 801 (2000). This portion of.the Controlled Substances Act provides:
The Congress makes the following findings and declarations:
(1) Many of the drugs included within this subchapter have a useful
and legitimate medical purpose and are necessary to maintain the
health and general welfare of the American people.
(2) The illegal importation, manufacture, distribution, and possession
and improper use of controlled substances have a substantial and
detrimental effect on the health and general welfare of the American
people.
(3) A major portion of the traffic in controlled substances flows
through interstate and foreign commerce. Incidents of the traffic
which are not an integral part of the interstate or foreign flow, such as
manufacture, local distribution, and possession, nonetheless have a
substantial and direct effect upon interstate commerce because-
(A) after manufacture, many controlled substances are
transported in interstate commerce,
(B) controlled substances distributed locally usually have been
transported in interstate commerce immediately before their
distribution, and
(C) controlled substances possessed commonly flow through
interstate commerce immediately prior to such possession.
(4) Local distribution and possession of controlled substances
contribute to swelling the interstate traffic in such substances.
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of controlled substances not only across state lines, but also across
international borders. Additionally, the Controlled Substances Act
regulates much more than mere possession, unlike the statute in Lopez,
which regulated mere possession of guns.166 Moreover, unlike the
statute in Lopez that had no congressional findings, the Controlled
Substances Act provides an enumerated list of findings. 167 A particularly
significant finding is that it is impossible to differentiate drugs that are
manufactured and distributed intrastate from those involved in
interstate movement. 168 Thus, under the Lopez analysis, Congress is
within its constitutional domain to regulate controlled substances. 169
However, merely recognizing that Congress has the power to regulate
does not mean that it has done so in accordance with the will of the
people.
The actions that the states and their citizens have undertaken in an
attempt to allow medicinal marijuana to be prescribed are laudable and
deserve due credence.170 However, this activity has been ineffectual
because of congressional power to control drugs for the safety and health
of the citizens in all states. This Note does not take issue with the federal
(5) Controlled substances manufactured and distributed intrastate
cannot be differentiated from controlled substances manufactured and
distributed interstate. Thus, it is not feasible to distinguish, in terms of
controls, between controlled substances manufactured and distributed
interstate and controlled substances manufactured and distributed
intrastate.
(6) Federal control of the intrastate incidents of the traffic in controlled
substances is essential to the effective control of the interstate incidents
of such traffic.
(7) The United States is a party to the Single Convention on Narcotic
Drugs, 1961, and other international conventions designed to establish
effective control over international and domestic traffic in controlled
substances.
Id.
166 See supra notes 148, 165 and accompanying text. Beyond possession, the Controlled
Substances Act also applies to manufacture, importation, and distribution. 21 U.S.C. § 801.
167 21 U.S.C. § 801(3); see also supra note 165.
168 See 21 U.S.C. § 801(5); see also supra note 165.
169 See supra notes 146-50 and accompanying text. Interestingly, the Supreme Court did
not analyze the Controlled Substances Act under the Lopez analysis in United States v.
Oakland Cannabis Buyers' Cooperative. 532 U.S. 483, 497 (2001). Rather, the Court merely
accepted the findings of Congress in order to decide if there was an implied necessity
defense to the Controlled Substances Act. Id. Thus, the Oakland decision may signal a
return to the Court's more deferential, pre-Lopez analysis. See supra note 143 and
accompanying text.
170 See supra notes 89-90 and accompanying text.
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government's ability to control drugs but rather with the way in which
this power has been exercised. Indeed, it is this power of the federal
government which must be called upon to effectuate lasting and uniform
change to the laws pertaining to medicinal marijuana. Drugs and the
regulation thereof involve issues which are more suitable to being dealt
with at the federal level because of the federal government's unique
national viewpoint. 17 Additionally, there is an international element to
the drug issue in that the federal government has the responsibility of
controlling drugs that are imported illegally.
Allowing states to decide for themselves how to deal with this issue
would result in a patchwork of laws that would create even more
problems because the states focus on solving problems within the
confines of their borders.172  For example, if one state allows for
medicinal marijuana and another does not, patients may be forced to
choose between leaving their prescription at home or not traveling out of
state. Similarly, a state that allowed for medicinal marijuana could be
faced with an influx of patients wishing to have the opportunity to have
a medicinal marijuana prescription. The medicinal use of marijuana is
not simply an issue that one state must address, but, rather, it must be
addressed at the federal level to ensure uniformity and clarity.
B. Mhat Hath Federalism Wrought?
Current federal laws forbid marijuana from being prescribed to
patients by their physicians who believe that these patients would
benefit from the medicinal uses of marijuana.173 Numerous states have
recognized not only the inherent unfairness of this restriction, but also
the lack of objective reasons for the continued prohibition of a medically
useful plant that grows naturally among the Earth's flora. 7 4 However,
any treatment of the medicinal marijuana issue at the federal level has
not produced results that could be considered positive to proponents of
medicinal marijuana. 175 Similarly, treatment of the issue has failed to
sufficiently provide any protection from prosecution under current
171 Holland, supra note 127, at 998 (noting that the "national perspective of the federal
government requires it to focus on problems and solutions that transcend state lines").
I7 James A. Gardner, The "States-as-Laboratories" Metaphor in State Constitutional Law, 30
VAL. U. L. REV. 475, 481 (1996); see also Holland, supra note 127, at 998 (discussing the idea
of the states as laboratories that Justice Louis Brandeis had proffered).
173 See supra notes 83-84.
174 See supra notes 89-90 and accompanying text.
175 See supra notes 101-08 and accompanying text.
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marijuana laws to patients who use medicinal marijuana. 176 As a result,
patients are left to weigh the costs, the possibility of prosecution and
prison sentences, with the benefits, the alleviation of the negative
symptoms and the concurrent devastating effects resulting from their
individual afflictions.1 7 Similarly, state courts are relegated to finding
new and unique methods of attempting to provide the necessary
protection from prosecution to certain parties, including patients,
physicians, manufacturers, and distributors. 178
The most recent discussion and ruling at the federal level on
medicinal marijuana has been provided by the United States Supreme
Court.179 The case of United States v. Oakland Cannabis Buyers' Cooperative
arose out of an initiative passed by the voters of California.180 The
initiative allowed physicians to prescribe marijuana to seriously ill
patients.' 8' The United States Attorney's Office brought a civil suit in
order to obtain an injunction that would shut down the medicinal
marijuana distribution centers.182 The injunction was granted by the
United States District Court for the Northern District of California.183
This ruling was reversed by the Ninth Circuit Court of Appeals. 8 4 That
court found that an implied exception for medical necessity existed in
the language of federal drug laws. 85 However, the Supreme Court did
not share the same interpretation. 86
176 See supra notes 116-20 and accompanying text.
177 GRINSPOON & BAKALAR, supra note 1, at 137.
178 See infra notes 193, 196 and accompanying text.
179 See supra notes 121-23 and accompanying text for further discussion.
180 United States v. Oakland Cannabis Buyers' Coop., 532 U.S. 483, 488 (2001).
181 See supra note 89.
182 Oakland Cannabis Buyers' Coop., 532 U.S. at 488.
183 United States v. Cannabis Cultivators Club, 5 F. Supp. 2d 1086, 1105 (N.D. Cal. 1998).
184 United States v. Oakland Cannabis Buyers' Coop., 190 F.3d 1109, 1115 (9th Cir. 1999).
185 Id. The judge granting the injunction was Charles Breyer, the younger brother of
United States Supreme Court Justice Stephen Breyer. Id. at 1111.
186 Oakland Cannabis Buyers' Coop., 532 U.S. at 498. The Court held that it was a mistake
for the court of appeals to order the district court to consider "criteria for a medical-
necessity exemption." Id. The criteria that the court of appeals had instructed the district
court to consider was whether there was
a class of people with serious medical conditions for whom the use of
cannabis is necessary in order to treat or alleviate those conditions or
their symptoms; who will suffer serious harm if they are denied
cannabis; and for whom there is no legal alternative to cannabis for the
effective treatment of their medical conditions because they have tried
other alternatives and have found that they are ineffective, or that they
result in intolerable side effects.
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The concurring opinion hinted that the Court's holding should be
narrowly construed.1 87 The Oakland Cannabis Cooperative was a
marijuana distributor, which, according to the Court, foreclosed the
medical necessity defense to the Cooperative.188 However, because none
of the Cooperative's patients were before the Court, Justice Stevens
noted that the holding should not be construed so as to establish with
any absolute certainty that the medical necessity defense would be
foreclosed to those patients charged with possession of medicinal
marijuana. 189
The controversy that has now arisen is that the state courts of
California have explicitly recognized a medical necessity defense to the
possession, cultivation, and, in some circumstances, the transportation of
medicinal marijuana under California state law.190 However, as the
concurring opinion in Oakland Cannabis Buyers' Cooperative noted, the
question of whether a similar defense exists under relevant federal law,
in particular the Controlled Substances Act, has been left open.191 The
court in Clauer v. Castro92 even went so far as to elucidate this distinction
in the disposition of that case. 93
Oakland Cannabis Buyers' Coop., 190 F.3d at 1115. The United States Supreme Court,
however, ruled that the Controlled Substances Act precluded the Court from taking into
account such evidence. Oakland Cannabis Buyers' Coop., 532 U.S. at 498.
187 Okland Cannabis Buyers' Coop., 532 U.S. at 498-99 (Stevens, J., concurring, joined by
Souter and Ginsburg, JJ.).
18 Id.
189 Id. Justice Stevens noted that "whether the defense might be available to a seriously ill
patient for whom there is no alternative means of avoiding starvation or extraordinary
suffering is a difficult issue that is not presented here." Id. at 499.
190 Clauer v. Castro, 2001 WL 725391, at *3 (N.D. Cal. June 19, 2001); People v. Mower,
122 Cal. Rptr. 2d 326 (Cal. 2002) (providing an elaborate discussion of the statutory defense
under California law); see also CAL. HEALTH & SAFETY CODE ANN. § 11362.5(b)(2)(d) (West
Supp. 2002) which provides:
Section 11357, relating to the possession of marijuana, and Section
11358, relating to the cultivation of marijuana, shall not apply to a
patient, or to a patient's primary caregiver, who possesses or cultivates
marijuana for the personal medical purposes of the patient upon the
written or oral recommendation or approval of a physician.
CAL. HEALTH & SAFETY CODE ANN. § 11362.5(b)(2)(d).
191 See supra note 189.
192 2001 WL 725391.
193 Clauer, 2001 WL 725391, at *3 n.1. The Clauer court noted that "[t]he United States
Supreme Court recently held that 'medical necessity is not a defense to manufacturing and
distributing marijuana.' ... The Court's decision, however, was based on the federal
Controlled Substances Act... and does not preclude a medical marijuana defense to a state
law violation." Id.
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From these decisions, it has become apparent that change is
needed.1 94 Even if a state court does recognize the medical necessity
defense, such a defense fails to provide adequate protection because
these defendants' liberties are then dependent upon erratic and
unpredictable judicial interpretations of the defense.1 95 Furthermore,
because of the uncertainty that surrounds the medical necessity defense,
patients, physicians, law enforcement, the courts, and the states are
finding it necessary to resort to unique and even more uncertain means
to protect those who wish to use medicinal marijuana.1 96 From this
uncertainty, it becomes readily apparent that, in order for certain and
194 See supra notes 121, 193 and accompanying text.
195 See Blum, supra note 117, at 938 (surveying state court cases in which the medical
necessity defense has been asserted both successfully and unsuccessfully); see also supra
notes 118-19 and accompanying text.
196 See, e.g., Jack Kresnak, Detroit Might Vote on Marijuana, DETROIT FREE PRESS, Nov. 23,
2001, at B1. In Detroit, Michigan, a political activist group named the Detroit Medical
Marijuana Initiative compiled enough signatures on a petition regarding medicinal
marijuana to get a proposed ordinance onto a city ballot to be voted upon in the next
election. Id. While this ordinance would not legalize medicinal marijuana, the ordinance
would essentially make the medicinal use of marijuana the lowest priority for the Detroit
Police Department. Id. The ordinance would accomplish this by barring the city from
spending money to prosecute anyone possessing three or fewer mature plants or the dried
equivalent for medicinal use. Id. A former Detroit police chief noted that allowing
medicinal marijuana would be the humane thing to do. Id. Also, a member of the group
responsible for the petition noted that "[wie have to find new ways of approaching this
thing as a means of eliminating this drug war which has been perpetrated on the
community." Id.; see also Bill Delaney, Maine Sheriff Proposes Using Seized Pot for Medicinal
Purposes, at http:/ /www.cnn.com/2000/HEALTH/alternative/05/12/medical.marijuana/
index.html (last visited Oct. 20, 2002). Mark Dion, sheriff of the largest county in Maine,
proposed giving the marijuana seized from drug busts to those who need the marijuana for
medicinal purposes. Delaney, supra. Sheriff Dion noted that "[tihe law is about making
sure we follow the rules; justice seeks the exceptions. And for me, supporting medicinal
marijuana was a journey to that exception." Id. However, not all law enforcement is on
board with the idea, as the director of Maine's Drug Enforcement Agency noted that "[1law
enforcement shouldn't be involved in the process of handing out any drug, that's not our
job. That's not our business. Our business is to identify and arrest drug dealers." Id. Yet
another innovative response to the restrictions imposed by federal law can be found in the
city of San Francisco. See Francine Vida, Going to Pot: San Francisco Voters to Decide If City
Should Grow Marijuana, at http://abcnews.go.com/sections/us/dailynews/marijuana
020731.html (last visited Oct. 22, 2002). The Board of Supervisors in San Francisco has put
forth an initiative to the voters that would allow the city itself to grow medicinal marijuana
that would then be distributed to citizen patients. Id. Presently, in order to get medicinal
marijuana, the patient is required to obtain a physician's permission and an identification
card from the San Francisco Department of Health. Id. However, because marijuana
remains illegal under federal law, the Drug Enforcement Agency ("DEA") has continued to
crack down on the cannabis clubs that would normally provide the patients with their
marijuana. Id. Indeed, the author of the initiative notes this distribution problem as the
impetus for the initiative. Id. See also supra note 193.
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lasting change to occur, it must be done both at the federal level and by
giving it the force of a statutory enactment.197 The result of such an
enactment would be more definite, uniform, and equitable holdings.
198
However, medicinal marijuana has continued to be a hotly contested
issue among the states, the federal government, and the citizenry of
both.199 Therefore, any proposal for change must take many interests
into account.20 0 First of all, the federal government maintains an interest
in protecting its citizens from the adverse effects of drugs that have been
classified under Schedule I, as, by definition, drugs within this Schedule
have been determined to have no currently accepted medical use.201
While the protection of health is indeed an important governmental
function, this interest is less persuasive to those afflicted with terminal
diseases, such as AIDS or cancer, who wish to use medicinal marijuana
to alleviate their suffering.202 Furthermore, there are the interests and
concerns of those who oppose the idea of allowing for medicinal
marijuana.2 3 Some have voiced a concern that marijuana will act as a
gateway drug to more harmful drugs.2°4 However, this "gateway
theory" is largely unfounded since it attempts to use a statistical
correlation between common and uncommon drugs to establish a causal
197 See infra Part IV, for section 1 of the model statute.
198 See infra Part IV, for section 1 of the model statute.
199 See GRAY, supra note 161, at 171-74 (providing an analysis of the aftermath following
the passage of California's Proposition 215 and Arizona's passage of Proposition 200).
200 JAMES L. NOLAN, JR., REINVENTING JUSTICE: THE AMERICAN DRUG COURT MOVEMENT
164 (2001) ("The intersection between philosophical statements, cultural sensibilities, and
actual judicial practices are complex and multifaceted .... [T]he political order generally,
and the law in particular, is influenced by culture even as it influences culture.").
201 21 U.S.C. § 812(b)(1)(B) (2000).
202 MARIJUANA, MEDICINE & THE LAW, supra note 5, at 103. For example, the following
quote is from the wife of a man who used medicinal marijuana for his cancer treatment:
After years of chemotherapy we knew the routine fairly well. Within
90 minutes, awake or asleep, my husband would begin his violent
bouts of vomiting. I decided to stay with Harris through the night in
case he needed my help. This time there was no vomiting. That night
Harris experienced the first full night of restful sleep he had had
following chemotherapy in nearly seven years of cancer and anti-
cancer treatments .... We wondered why someone had not told us
sooner and why my husband had gone through all those years of
needless suffering.
Id.
203 See supra notes 93-99 and accompanying text.
204 See supra text accompanying note 93.
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explanation. 205  Another concern that those opposed to medicinal
marijuana have noted is that marijuana may have certain negative
physiological effects on its users.2 6 While this is certainly a valid
concern, the risks and benefits should be determined and assessed by
individual patients and their physicians just as any other form of
medicine would be evaluated prior to being prescribed.207
The critics of medicinal marijuana have also raised concerns
regarding the costs to the environment, an increase in workplace
accidents, and an increase in crime.20 8 However, these concerns can all
be ameliorated by a complete statute which takes all of these concerns
into account. Moreover, it should be remembered that allowing doctors
to prescribe marijuana would not simply legalize all forms of marijuana.
Rather, it would provide the necessary protection to those patients who
would benefit from such an allowance and also give protection to those
who would provide the medicinal marijuana. Not all of the interests
involved are co-extensive, and, as a result, some interests must be given
greater accord than others.2°9  The following proposal necessarily
205 ZIMMER & MORGAN, supra note 29, at 32-37. Studies have shown that out of one
hundred marijuana users, only one would also be a regular user of cocaine. Id. at 34.; see
also HANSON ET AL., supra note 32, at 387 (noting that factors such as personality and social
environment are much more important factors for determining whether a person will move
on to harder drugs).
206 See supra note 94 and accompanying text.
207 HANSON ET AL., supra note 32, at 368-69 (noting that the rise in marijuana potency is a
major factor in the increase of emergency room visits attributed to marijuana). This
concern regarding the potency of medicinal marijuana is addressed by section 5 of the
model statute in the licensure requirements for manufacturers of medicinal marijuana. See
infra Part IV, for section 5 of the model statute.
208 See supra notes 96-98 and accompanying text.
209 See JEROME H. SKOLNICK & JAMES J. FYFE, ABOVE THE LAW: POLICE AND THE EXCESSIVE
USE OF FORCE 116 (1993). In this book, the authors evaluate the idea of a "drug war" and
conclude that
This wrongheaded emphasis has led us to evaluate the performance of
the police and the criminal justice system by counting bodies-bodies
arrested, convicted, confined, and executed-rather than by trying to
determine whether our war efforts have made our streets safer and
more civil. The current war on drugs has made cynics of much of the
population, adding to them the great numbers of street-level police
officers. On the streets, too many cops long ago stopped believing that
their lives were on the line for anything that could be regarded as a
viable grand strategy. Instead, most cops see drug and crime wars for
what they are: politics, in all the pejorative senses of that word.
Id. at 115-16. Detroit Police Chief Jerry Oliver has expressed similar sentiments by noting
that "[w]e will never arrest our way out of this problem." John Stossel, Just Say No:
Government's War on Drugs Fails, at http://abcews.go.com/onair/2020/stossel-drugs_
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considers the interests of those afflicted with debilitating diseases and
conditions to be those which are first and foremost among the competing
interests.210
The public perception of medicinal marijuana has been plagued by
misunderstanding and unfortunate associations with certain
subcultures.2 1 However, there are certain indications that this negative
perception is changing. 212 One of the most significant developments is
that the Drug Enforcement Agency has recently given its approval for
marijuana studies to be conducted at the University of California at San
Diego.213 Additionally, certain members of the United States Supreme
Court have indicated that marijuana for medicinal purposes, with
further study, may be feasible. 21 4 Certainly, the states which have made
attempts to permit the use of medicinal marijuana under state law
provide further indication that the issue will not fade.215
What these examples show is that marijuana usage for medicinal
purposes no longer appears to be an illusory idea. However, because of
the conflicting interests involved and the difficulty that is created when
020730.html (last visited Oct. 8, 2002). Police Chief Oliver went on to note that "[c]learly,
we're losing the war on drugs in this country [and] it's insanity to keep doing the same
thing over and over again." Id. Similarly, Superior Court Judge James Gray from Orange
County, California, noted that "[wihat we're doing now has failed. In fact it's hopeless.
This is a failed system that we simply must change." Id. Interestingly, Federal Bureau of
Investigation Director Robert Mueller has determined that 400 agents will be redirected
from drug cases to working to combat terrorism. Bradley Cole, FBI Offices Taking Focus Off
Fighting Drugs, TIMES OF NORTHWEST IND. (VIDETTE EDITION), June 1, 2002, at Al.
210 See supra note 29 and accompanying text (discussing diseases and conditions that
debilitate individuals who would benefit from medicinal marijuana).
211 See HOWARD S. BECKER, OUTSIDERS: STUDIES IN THE SOCIOLOGY OF DEVIANCE 82-83
(1963) (noting the negative association of marijuana with early jazz musicians); HANSON ET
AL., supra note 32, at 368 (noting marijuana and its association with the beat generation of
the 1950s and the hippie counterculture of the 1960s).
212 See Associated Press, Medical Marijuana Popular at Polls (noting the success of
medicinal marijuana initiatives in the 1998 elections), available at http://www.cnn.com/
ALLPOLITICS/stories/1998/11/03/election/ballots/medical.marijuana/ (last visited
Oct. 8, 2000). For an examination of how many countries in Europe are addressing the
marijuana issue, see Gregory Katz, Europe Loosens Its Pot Laws, ROLLING STONE, July 4-11,
2002, at 55-56.
213 See Associated Press, supra note 87. This article discusses the recent final approval by
the DEA for the Center for Medicinal Cannabis Research to conduct studies regarding the
medicinal usefulness of marijuana. Id. Asa Hutchinson, DEA Administrator, was quoted
as saying that "[tihe question of whether marijuana has any legitimate medical purpose
should be determined by sound science and medicine." Id.; see also supra note 87.
214 See supra notes 114, 189 and accompanying text.
215 See supra note 90 and accompanying text.
Flether: The Medical Necessity Defense and De Minimis Protection for Patie
Produced by The Berkeley Electronic Press, 2003
1020 VALPARAISO UNIVERSITY LAWREVIEW [Vol. 37
attempting to provide for clarity and uniformity, a complete and
authoritative edict must come from the federal level.216 While the states
have attempted to find solutions on their own, federal law still trumps
states' laws on this issue.21 7 The following proposal endeavors to
provide a complete, clear, and uniform statute that could be enacted at
the federal level in order to accomplish all of these goals.
IV. CONTRIBUTION: A PROPOSED MODEL FEDERAL STATUTE FOR THE
ALLOWANCE OF THE USE OF MARIJUANA FOR MEDICINAL PURPOSES
Because the medical necessity defense is often accompanied by
dilemmas in burdens of proof and establishment of uniformity, it should
be considered de minimis protection at best.218 In order to provide
uniform application of controlled substance laws, the first step must
include a rescheduling of marijuana from its current position in Schedule
I to Schedule 111.219 By doing so, rescheduling will allow for greater
options in finding an agreeable solution to the quandary surrounding
medicinal marijuana.
Rescheduling marijuana into Schedule III would initially allow for
greater research into further uses of marijuana in the treatment of
various illnesses. A rescheduling would also allow for establishing a
licensing scheme for local growers to be able to provide the marijuana
itself to doctors who would prescribe marijuana for their patients. Such
a licensing scheme would benefit the state by raising revenue through
taxes. Moreover, by establishing a preference for smaller operations,
these small businesses and farms would remain viable in relation to the
corporate farms and commercial drug manufacturers. 220 While it could
be asserted that individuals to whom medicinal marijuana is prescribed
should be allowed to grow their own marijuana for personal use, such a
216 See supra notes 199-210 and accompanying text.
217 See supra notes 88-90, 157-69 and accompanying text.
218 See supra notes 116-20 and accompanying text.
219 See supra note 83 and accompanying text.
220 Reuters, Drug Industry Most Profitable in U.S., at http://cnn.com/2001/HEALTH/11/
30/drug.profits.reut/index.html (last visited Dec. 30, 2001). This article notes that
"[p]rofits as a percent of revenues for the pharmaceutical industry have been more than
four times the median rate for all Fortune 500 firms in the late 1990's." Id. Furthermore,
"[t]he result is the average price of a prescription is now $45, double what it was ten years
ago." Id.; see also Ann Zimmerman & David Armstrong, How Drug Makers Use Pharmacies
To Push Pricey Pills, WALL ST. J., May 1, 2002, at Al (discussing how large drug companies
pay pharmacies for calling and mailing letters to the pharmacy's customers in order to
market more expensive prescription drugs).
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situation would provide little assurance of good faith growers. Issues
such as the quality of the marijuana and prevention of misuse by those
without a physician's prescription would be difficult to control. 221
Moreover, most of those to whom marijuana would be prescribed would
not be physically able to undertake such a task because of their particular
illnesses. The current version of the Controlled Substances Act allows
for a licensing scheme; however, it makes licensing contingent upon
approval by the Attorney General.m Instead, such a plan should be
established by the individual states. This would ensure local oversight
of those who would be issued such licenses. While the states would be
responsible for issuing these permits, uniform requirements and
restrictions need to be established.
For growers to obtain a license, they need to show that the place
where the growing occurs is secure against persons trying to obtain the
marijuana illegally. Similarly, an accounting of the amount of marijuana
grown and distributed must be provided to the relevant state authorities.
Considerations of health and safety would similarly need to be
addressed. 2  An important aspect of this consideration would involve
restrictions on fertilizers and pesticides. 224 Also, the growers would be
required to submit samples for testing to determine the proper content of
the tetrahydrocannabinol. 225 These provisions would provide physicians
with the information to tailor the amount prescribed to the particular
patient. Implementation of such a scheme would not only benefit the
small businesses that would provide the marijuana but also those
patients whose suffering could be alleviated by allowing physicians to
prescribe marijuana. The following is a proposed model federal statute
designed to address these issues:
221 See Kurt Ullman, Marijuana's Active Ingredient May Help Control Spasticity: Does Study
Hold Promise for MS Patients?, at http://my.webmd.com/content/article/1728.55346 (last
visited Oct. 8, 2002) (noting the difficulty of assuring the quality of illegally purchased
marijuana); see also Delaney, supra note 196 (noting federal and state authorities' concern
with adulteration by the cultivator in response to a proposal for distributing seized
marijuana to medical patients).
222 See 21 U.S.C. § 823 (2000).
2n See GRINSPOON & BAKALAR, supra note 1, at 137 (discussing the risks and benefits of
marijuana when used as medicine); see also Ullman, supra note 221 (noting the difficulty of
ascertaining the mixture of chemicals that could be found in illegally purchased
marijuana).
224 See supra note 96 and accompanying text.
221 See supra note 30.
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Title: The Use of Marijuana for Medicinal Purposes
Section 1: Goals and Purposes
The United States of America does hereby recognize that some
of its citizens, because of terminal or debilitating conditions
and diseases, may benefit from the use of medicinal marijuana.
Diseases and conditions benefiting from the use of medicinal
marijuana include, but are not limited to, cancer and nausea
caused by chemotherapy, AIDS and its resulting wasting
syndrome, glaucoma, seizures, multiple sclerosis, depression,
and Crohn's disease. The purpose of this statute is to enable
citizens with such afflictions to obtain and use marijuana for
medicinal purposes without the fear of harassment, arrest, or
prosecution. Therefore, compassion for patients with such
diseases and conditions necessarily determines that the goal of
this statute is that such citizens shall obtain the benefits that
marijuana provides in relation to an individual's particular
affliction. Any subsequent interpretation of this statute shall
abide by these goals and purposes.
Commentary
Section 1 is included as a preamble to the proposed statue. It
broadly defines the goals and purposes behind the enactment of this
statute for two reasons: (1) it provides a recognition of those patients
who have suffered unnecessary pain and discomfort as a result of the
illegal status of marijuana; and (2) the goals and purposes of the statute
should aid in any subsequent legislative or judicial interpretation.
Section I is modeled after California's Compassionate Use Act of 1996.226
Section 2: Definitions
As used in this statute:
(a) "Marijuana" refers to the whole cannabis plant and/or its
derivatives, which includes, but is not limited to, the seeds,
stems, stalks, flowers, and leaves. This definition is intended
to cover all known, and heretofore undiscovered, species of the
cannabis plant.227
226 CAL. HEALTH & SAFETY CODE § 11362.5 (West Supp. 2002).
227 See supra notes 28-30 (discussing other definitions of marijuana).
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(b) "Medicinal Marijuana" means marijuana which has been
grown, distributed, or prescribed legally and for medicinal
purposes. This definition shall not cover marijuana which has
been illegally grown, distributed, or obtained. Thus, statutes
pertaining to illegal marijuana and their respective definitions
shall apply and are, therefore, not altered by this statute.
(c) "Prescribing Physician" means one who has the authority
under section 5(a) of this statute to prescribe marijuana to
patients. This definition shall include medical doctors,
dentists, psychiatrists, and any other such profession which,
under current laws, are permitted to practice medicine and to
issue forth prescriptions for drugs which are not available over
the counter. The prescribing physician must include his
signature upon any prescription for medicinal marijuana in
order for such prescription to be valid.
(d) "Qualifying Patient" means the individual to whom a
valid prescription is issued by a prescribing physician, as
defined in this section.
(e) "Adequate Supply" means that which is not more than
reasonably necessary to assure the uninterrupted availability
of marijuana for the purpose of alleviating the symptoms or
effects of a qualifying patient's debilitating medical condition;
provided that an "adequate supply" shall not exceed five
mature marijuana plants, four immature marijuana plants,
and two ounces of usable marijuana per each mature plant.2 8
(0 "Diseases" and "Conditions," under this statute, shall be
broadly interpreted to allow physicians the latitude necessary
to make individual assessments as to which of their patients
would benefit from being prescribed medicinal marijuana.
(g) "Valid Prescription" means one issued by a prescribing
physician, as defined in this section, and subsequently filled by
a pharmacist, as defined in this section. A valid prescription
requires, and must include, the signatures of both the
prescribing physician and of the pharmacist who fills such
prescription.
U8 HAW. REV. STAT. § 329-121 (Supp. 2001). The definition of "adequate supply" in this
proposed statute mirrors that of the Hawaii statute; however, it allows a slight increase in
amount. Id.; see also supra note 90.
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(h) "Valid Research" and "Research Facility" mean research
conducted in facilities pursuant to and in accordance with
section 7 of this statute.
(i) "Pharmacist" means one who is licensed to fill valid
prescriptions that have been issued by a prescribing physician.
Pharmacists so defined must include their signature upon a
prescription that they have filled in order for the prescription
to be valid.
(j) "Manufacture" means the production, preparation,
propagation, compounding, or processing of marijuana for
medicinal purposes. This definition is intended to encompass
any packaging or repackaging of such substance or labeling or
relabeling of its container.229
(k) "Manufacturer" means a person who manufactures, as
defined by this section, marijuana to be used for medicinal
purposes.230
(1) "Distributor" means a person involved in delivering
marijuana to be used for medicinal purposes to a prescribing
physician, pharmacist, or licensed research facility.
(m) "Importer" means one who brings medicinal marijuana,
in all forms, into the United States for purposes of delivering
the marijuana to a licensed research facility. Delivery of
imported medicinal marijuana to any other entity shall be
prohibited under this statute.
Commentary
Section 2 is an attempt at clearly defining the terms used in the
statute. Some definitions have been broadly defined purposefully in
order to provide those involved with the greatest protection under the
law and in order to be in accordance with the goals and purposes
established in section 1. In the past, courts have struggled with defining
marijuana for enforcement purposes.231 Thus, this definition section
229 See 21 U.S.C. § 802(15) (2000). This subsection is modeled after the definition of
manufacture under the Controlled Substances Act. Id. § 801.
- Id. § 802(14).
21 See State v. Navaro, 26 P.2d 955, 957 (Utah 1933). The Utah Supreme Court held:
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should be interpreted as to be one of inclusion, rather than exclusion,
thereby providing maximum protection.
Section 3: Effect on Current Marijuana Laws
This statute is enacted in order to allow medicinal marijuana
to be validly prescribed by a physician. Therefore, in order to
establish this statute and to accomplish its goals, all federal
and state laws regarding medicinal marijuana are hereby
superseded. However, nothing in this section, nor in this
statute, shall preempt valid laws regarding marijuana
possessed, manufactured, distributed, or transported in
contravention of this statute. Thus, marijuana which is not
permitted by license or prescription under this statute remains
subject to the heretofore established criminal laws.
Commentary
Access to medicinal marijuana should not be dependent or
contingent upon the state in which a person resides. Therefore, this
section establishes necessary uniformity among state and federal laws
regarding medicinal marijuana. Uniformity is required for apprising all
involved of their rights and obligations and of possible penalties for
nonconformity to the statute. Moreover, uniformity is required to ensure
the equal administration of the laws contained under this statute. This
statute, however, is not intended to provide an across-the-board
legalization of marijuana; thus, nonmedicinal marijuana remains subject
to the established criminal laws of the states and federal government.
Section 4: Rescheduling
This section does hereby reschedule marijuana from Schedule I
to Schedule III. This section is intended to recognize that
marijuana, when used for medicinal purposes, meets the
requirements enunciated under 21 U.S.C. § 812. 23 2 This
section and statute establish that marijuana, when used
From our reading on the subject we have reached the conclusion that
as used in our statute it means or refers to the preparation or product
from the plant scientifically known as cannabis sativa, and is the same
product or preparation described in the technical dictionaries and
books as cannabis.
Id.
232 See supra note 83 and accompanying text.
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medicinally, has a potential for abuse that is less than drugs in
Schedules I and II, has a currently accepted medical use in the
United States, and may lead to moderate or low physical
dependence or high psychological dependence.233 Schedule III
is a less restrictive schedule under federal law and thereby
permits distribution to the qualifying patient by use of
prescription.234
Commentary
Section 4 is a necessary predicate for the allowance of marijuana for
medicinal purposes. Under current law, marijuana is scheduled under
Schedule I and, as such, cannot be legally prescribed for use.235
However, a transfer from Schedule I to Schedule III would, therefore,
enable a qualifying physician to prescribe marijuana to patients for
medicinal purposes.
Section 5: Licensing
In order to effectively provide medicinal marijuana to qualified
patients and to oversee the administration of a workable
distribution scheme, it is necessary to establish a set of
guidelines which shall provide licenses to those involved in the
various phases of providing for the use of medicinal
marijuana. The following subsections identify those who are
or are not required to obtain licensure under both federal and
state law. While these categories of who must obtain licenses
are mandatory with respect to the states, the actual procedural
requirements for obtaining a license shall be determined by the
individual state. The state may establish more stringent, but
not less stringent, application procedures than those
mandatory upon the federal government. Such state-
233 See supra note 83 and accompanying text.
234 See 21 U.S.C. § 829(b) (2000). This section provides:
Except when dispensed directly by a practitioner, other than a
pharmacist, to an ultimate user, no controlled substance in schedule III
or IV, which is a prescription drug as determined under the Federal
Food, Drug, and Cosmetic Act, may be dispensed without a written or
oral prescription in conformity with section 503(b) of that Act. Such
prescriptions may not be filled or refilled more than six months after
the date thereof or be refilled more than five times after the date of the
prescription unless renewed by the practitioner.
Id.
235 See supra note 83 and accompanying text.
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established guidelines must not contravene the goals and
purposes of this statute as defined in section 1. The guidelines
following shall be established by the federal government and
shall be used as a model for the individual states:
(a) Those who do not require additional licensure under this
statute:
(1) "Prescribing physicians" shall not be required to
obtain federal or state licensure in order to prescribe
marijuana for medicinal use. This provision does not,
however, infringe upon the requirement that prescribing
physicians must have a valid license to practice medicine
in their respective states. Prescribing physicians also
must recognize that they continue to be bound by the
ethical canons and codes which apply to their profession.
This subsection shall apply to those defined under section
2(c).
(2) "Pharmacists" shall not be required to obtain federal
or state licensure in order to fill prescriptions issued by a
prescribing physician for marijuana to be used for
medicinal purposes. This provision does not, however,
infringe on the requirement that they must have a valid
license to fill prescriptions in the respective states.
Pharmacists also must recognize that they continue to be
bound by the ethical canons and codes which apply to
their profession. This subsection shall apply to those
defined under section 2(i).
(b) Those who shall require licensure under this statute:
(1) "Manufacturers," as defined by section 2(k) of this
statute, shall be required to obtain a license by the
qualifications enunciated under subsection (c) of this
section. Furthermore, the Food and Drug Administration
shall oversee and establish the necessary guidelines in
providing for:
a. Scientific testing for quality of the medicinal
marijuana;
b. Restrictions and guidelines pertaining to the use
of pesticides by manufacturers;
20031 1027
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c. Restrictions and guidelines for proper labeling of
the medicinal marijuana. Proper labels shall include:
a measurement of the amount provided, the scientific
name and species of plant contained therein, the
measure of the active ingredient contained by the
medicinal marijuana, any additional requirements
that the FDA may require, and any additional
requirements established by the individual state.
(2) "Distributors," as defined by section 2() of this
statute, shall be required to obtain a license by the
qualifications enunciated under subsection (c) of this
section. Licensed distributors will thus be the sole means
of conveyance for wholesale or premarket medicinal
marijuana. Transportation of medicinal marijuana by a
qualifying patient after a valid prescription has been filled
is to be governed by the dictates of section 6 of this
statute.
(3) "Importers," as defined by section 2(m) of this statute,
shall be required to obtain a license by the qualifications
enunciated under subsection (c) of this section. Scientific
research on medicinal marijuana should not be inhibited;
thus, importation of medicinal marijuana shall be allowed
under this section for delivery to valid research facilities
only. Delivery of imported medicinal marijuana to any
other entity shall be prohibited under this statute. A
license on importers is thus required in order to
distinguish legal, medicinal marijuana from that
marijuana which is illegally imported.
(c) Qualification for Licensure:236
No license shall be issued under this section unless and until
the applicant therefor has furnished proof satisfactory to
[insert here proper official designation of state orfederal officer
or board] that:
236 See GERALD F. UELMEN & VICrOR G. HADDOX, DRUG ABUSE AND THE LAW 521 (1974).
This text provides analysis of the Uniform Narcotic Drug Act that was proposed for states
to ratify prior to passage of the Marijuana Tax Act of 1937. Id. This Act is no longer in
effect since passage of the Controlled Substances Act. Id. However, the Uniform Narcotic
Drug Act provided a model for licensing under section 5. Id.
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(1) The applicant, individual, corporation, or association
is equipped as to land, buildings, and paraphernalia
properly to carry on the business that shall be properly
described in their application.
(2) No license shall be granted to any individual,
corporation, or association who has within five years been
convicted of a willful violation of any law of the United
States, or of any state, relating to opium, coca leaves, or
other narcotic drugs, or to any person who is a narcotic
drug addict.
(3) The [insert here proper official designation of state or
federal officer or board] may suspend or revoke any license
for cause.
(4) In issuing licenses, [insert here proper official
designation of state orfederal officer or board] shall, to the
degree feasible, show a preference for both local and small
businesses.
(5) In issuing licenses, [insert here proper official
designation of state or federal officer or board] shall limit
the number of licenses issued to a number which will
allow for the proper administration and oversight of the
particular licensing scheme by [insert here proper official
designation of state or federal officer or board].
2003] 1029
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Commentary
Section 5(b), which establishes those who must obtain licenses, is to
be mandatory on both the federal government and the states. However,
section 5 further recognizes that the states must be overseers at the local
level and, thus, may set licensing requirements in order to efficiently
oversee the licensing process. The states shall be allowed to do this, even
though the overall goal of the legislation is uniformity, because section 5
recognizes that the individual state may be subject to unique
circumstances that make the administration of a licensing scheme more
difficult in that state. Thus, section 5(c) provides requirements which are
mandatory upon the federal government. The states, however, may
enact more stringent guidelines as long as the goals and purposes
established in section 1 of this statute are not violated. The states may
not, however, enact guidelines which are less stringent.
Section 6: The Prescription of Marijuana for Medicinal Purposes
The following section is applicable only to the qualifying
patient, as defined in section 2(d) of this statute:
(a) A valid prescription shall be adequate to prevent arrest and
prosecution for possession of validly obtained and validly
prescribed medicinal marijuana; thus, no license for a
qualifying patient is necessary.
(b) A qualifying patient shall carry and make available the
qualifying patient's valid prescription to a requesting officer of
the state or federal government. A valid prescription must
accompany the medicinal marijuana at all times until the
amount prescribed and described within the valid prescription
has been depleted. A valid prescription must similarly
accompany the medicinal marijuana during the transferal of
the medicinal marijuana from the pharmacist to the qualifying
patient's home.
(c) The total amount of medicinal marijuana that any
qualifying patient is allowed to maintain in his possession
shall be an adequate supply, as defined in section 2(e).
(d) The penalty for a qualifying patient in possession of
medicinal marijuana without a valid prescription is to be
determined in accordance with section 8.
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(e) Qualifying patients shall not make use of medicinal
marijuana outside of their domicile or other approved areas.
Nor shall qualifying patients operate any motor vehicle while
under the influence of medicinal marijuana. Violations of this
section shall be penalized in accordance with section 8.
Commentary
Section 6 is applicable only to the qualifying patient. It is necessary
to make particular restrictions apply to those who will be utilizing the
medicinal marijuana. The purpose of these restrictions is to ensure less
confusion for police officers and other agents of the federal and state
governments regarding what is legal, medicinal marijuana and what is
illegal marijuana. An additional benefit of these restrictions is that
qualifying patients should not receive any unreasonable harassment for
possession of medicinal marijuana if they can present their valid
prescription to government agents.
Section 7: Provision for Further Research and Research Facilities
In recognition of the fact that science and the respect for its
findings are furthered by scientific investigation, further
research and new research facilities shall not be inhibited by
the laws of the United States. However, this recognition is
not to diminish the necessary limits and procedures contained
herein. Any further research and research facilities, currently
operational and those established subsequently to enactment of
this section, shall abide by the following guidelines:237
(a) Any research facility that desires to perform research on
marijuana in order to establish new uses for medicinal
marijuana or safer procedures for administering medicinal
marijuana shall submit a "Proposal for Research."
(b) A Proposal for Research must, at a minimum, contain the
following information:
(1) The location of the proposed research facility;
737 See CAL. HEALTH & SAFETY CODE § 11362.9 (West Supp. 2002) (establishing the
California Marijuana Research Program). The guidelines in section 7 are modeled after this
California statute.
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(2) The names and qualifications of the proposed
researchers who will be working on the proposed research
project,
(3) A thorough description of the research that is to take
place, including the thesis for the project and its
applicability to medicinal marijuana; and
(4) A complete accounting of sources of funding for the
project, which shall be updated as new sources of funding
are provided.
(c) The Food and Drug Administration shall appoint a
Qualification Committee to evaluate proposals submitted
pursuant to section 7(a).
(d) The Qualifications Committee shall evaluate proposals
based on the following criteria:
(1) The degree to which the proposed research would
provide new information to the scientific community;
(2) The efficacy of the scientific methods chosen by the
researchers involved;
(3) The amount offunding that the proposal carries, to the
extent that the project will be able to maintain
independent and objective evaluation offindings; and
(4) The qualifications of those to be involved in the
research project.
(e) Any research proposal accepted by the Qualifications
Committee shall also require periodic review and reapproval,
at a minimum, every 365 days by the Committee in order to
determine the continued efficacy of the project.
Commentary
This section is intended to recognize the need for further research
into the medicinal uses of marijuana. Research should continue in the
hope that new and beneficial uses for marijuana as medicine may be
discovered and subsequently utilized. In order to properly administer
and oversee such research, the creation of a Qualifications Committee is
necessary to prevent so-called "junk science."
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Section 8: Penalties
In recognition of the fact that the intent of this statute is not to
provide an across-the-board legalization of marijuana, federal
law, in accordance with the United States Sentencing
Guidelines, and related state laws, shall not be preempted by
this section for those in possession of marijuana without a
valid license or valid prescription.238 However, the following
special penalties shall apply to:
(a) Prescribing Physicians
(1) A prescribing physician who makes available
medicinal marijuana to an individual for purposes other
than legitimate medicinal use shall have his license to
practice medicine withdrawn for a period of not less than
one year. A mechanism to appeal such withdrawal and to
apply for reinstatement shall be established by the state
licensing board.
(2) However, no physician shall be punished under this
statute for having recommended medicinal marijuana to a
qualifying patient.239
(b) Valid Researchers and Research Facilities
Any violation of the prohibitions contained within this statute
shall be cause for the Qualifications Committee to withdraw
permission for such researchers or research facilities to
continue their research. Thereafter, any acts performed by the
researcher or research facility are to be judged under the
relevant criminal laws.
(c) Qualifying Patients
Any qualifying patients found to be in violation of section 6(d)
or section 6(e) of this statute shall be exposed to the following
penalties:
2M See generally 21 U.S.C. §§ 841-849 (2000) (defining offenses and penalties under the
Comprehensive Drug Abuse Prevention and Control Act).
239 See CAL. HEALTH & SAFETY CODE § 11362.5(c). This section provides that,
"[n]otwithstanding any other provision of law, no physician in this state shall be punished,
or denied any right or privilege, for having recommended marijuana to a patient for
medical purposes." Id.
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(1) Loss of ability to have medicinal marijuana prescribed
to them for no more than six months;
(2) A jail sentence of no more than one year, in addition
to the relevant criminal penalties already provided under
the United States Sentencing Guidelines;
(3) Fines not to exceed $1,000.00; and
(4) Any individuals to whom this statute applies shall
have their penalty increased twofold beyond the normal
sentence given for the respective transgression for making
available any amount of medicinal marijuana to any
minor under the age of eighteen.
Commentary
Penalties under this statute are not intended to preempt any of the
state or federal criminal laws respecting illegal marijuana. Marijuana
defined as medicinal under section 2(b) is not defined as illegal and is,
therefore, exempt from such criminal laws. Because of the fact that some
marijuana is defined as illegal and some is defined as legal, those who
benefit in any way from medicinal marijuana shall be held to higher
standards and penalties for their transgressions of applicable laws.
VI. CONCLUSION
Marijuana used as medicine is not a new idea. Throughout history
people have used marijuana for numerous purposes, including medicine.
However, since 1937 marijuana has been forbidden for any purposes.
The time for a change is significantly overdue. This Note attempts to
establish the reasons why this change is overdue. Although the medical
necessity defense may be workable in some contexts, it is merely an
illusory panacea when it comes to medicinal marijuana. Such a defense
provides inconsistent results to patients and fails to give any protection
to physicians, manufacturers, and distributors. While Congress has not
exceeded its authority in regulating medicinal marijuana, it is the
manner in which it has chosen to regulate medicinal marijuana that is
flawed. Those afflicted with debilitating diseases and conditions that
would benefit from the healing properties of medicinal marijuana should
no longer be made to suffer because of outmoded, inefficient, and
discriminatory laws that prohibit a naturally occurring plant known as
marijuana.
Ronald Timothy Fletcher
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